TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-71384	Ethanol oxidation	5.18486950007112e-06	-12.1697658853418	12	5	0.0203252032520325	246	10287	130,127,126,125,216	ADH6,ADH4,ADH1C,ADH1B,ALDH1A1
R-HSA-397014	Muscle contraction	7.60617386915872e-06	-11.7865502892455	204	17	0.0691056910569106	246	10287	25802,7136,6546,6327,816,7140,60598,4634,4638,482,6329,89822,775,10398,93408,4632,6326	LMOD1,TNNI2,SLC8A1,SCN2B,CAMK2B,TNNT3,KCNK15,MYL3,MYLK,ATP1B2,SCN4A,KCNK17,CACNA1C,MYL9,MYL10,MYL1,SCN2A
R-HSA-211945	Phase 1 - Functionalization of compounds	5.68362941381564e-05	-9.77533545499323	109	11	0.0447154471544715	246	10287	216,125,126,127,66002,2326,64757,5740,130,51302,2327	ALDH1A1,ADH1B,ADH1C,ADH4,CYP4F12,FMO1,MARC1,PTGIS,ADH6,CYP39A1,FMO2
R-HSA-5632681	Ligand-receptor interactions	0.00069215094899396	-7.27570649175011	8	3	0.0121951219512195	246	10287	3549,2619,64399	IHH,GAS1,HHIP
R-HSA-3781865	Diseases of glycosylation	0.000939151979643351	-6.97053323919741	85	8	0.032520325203252	246	10287	9719,6382,143662,7057,10417,4958,4589,157869	ADAMTSL2,SDC1,MUC15,THBS1,SPON2,OMD,MUC7,SBSPON
R-HSA-418346	Platelet homeostasis	0.00146717802589354	-6.5244144334734	91	8	0.032520325203252	246	10287	5136,8654,2788,9127,6546,5593,338,5023	PDE1A,PDE5A,GNG7,P2RX6,SLC8A1,PRKG2,APOB,P2RX1
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.00166253273538298	-6.39941309517219	22	4	0.016260162601626	246	10287	2149,2162,5624,2147	F2R,F13A1,PROC,F2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.00166253273538298	-6.39941309517219	22	4	0.016260162601626	246	10287	8549,8325,343637,340419	LGR5,FZD8,RSPO4,RSPO2
R-HSA-217271	FMO oxidises nucleophiles	0.00168175808831627	-6.38791555160602	3	2	0.00813008130081301	246	10287	2326,2327	FMO1,FMO2
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.002747348613101	-5.8971189730768	59	6	0.024390243902439	246	10287	9719,4589,10417,157869,143662,7057	ADAMTSL2,MUC7,SPON2,SBSPON,MUC15,THBS1
R-HSA-382551	Transmembrane transport of small molecules	0.00314081867715057	-5.7632717878377	677	28	0.113821138211382	246	10287	482,55867,6508,55089,5244,1188,10991,2030,10396,30061,25769,816,53919,22802,79895,121601,6563,6546,2788,55283,360,41,5172,107,364,225,23539,8001	ATP1B2,SLC22A11,SLC4A3,SLC38A4,ABCB4,CLCNKB,SLC38A3,SLC29A1,ATP8A1,SLC40A1,SLC24A2,CAMK2B,SLCO1C1,CLCA4,ATP8B4,ANO4,SLC14A1,SLC8A1,GNG7,MCOLN3,AQP3,ASIC1,SLC26A4,ADCY1,AQP7,ABCD2,SLC16A8,GLRA3
R-HSA-2029485	Role of phospholipids in phagocytosis	0.0031525956874526	-5.75952913770635	26	4	0.016260162601626	246	10287	5295,2214,2209,122618	PIK3R1,FCGR3A,FCGR1A,PLD4
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.00404505664432021	-5.51025972502951	14	3	0.0121951219512195	246	10287	11001,51302,5740	SLC27A2,CYP39A1,PTGIS
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.00415935774244621	-5.48239460546319	28	4	0.016260162601626	246	10287	5330,113026,122618,51196	PLCB2,PLCD3,PLD4,PLCE1
R-HSA-5576892	Phase 0 - rapid depolarisation	0.00507891457862908	-5.28265770584569	47	5	0.0203252032520325	246	10287	6329,6327,6326,816,775	SCN4A,SCN2B,SCN2A,CAMK2B,CACNA1C
R-HSA-1483249	Inositol phosphate metabolism	0.00507891457862908	-5.28265770584569	47	5	0.0203252032520325	246	10287	122618,51196,5330,113026,51477	PLD4,PLCE1,PLCB2,PLCD3,ISYNA1
R-HSA-445095	Interaction between L1 and Ankyrins	0.00536332651559665	-5.22817087782203	30	4	0.016260162601626	246	10287	6326,6329,6327,288	SCN2A,SCN4A,SCN2B,ANK3
R-HSA-3000471	Scavenging by Class B Receptors	0.00543044649847098	-5.21573392033747	5	2	0.00813008130081301	246	10287	948,338	CD36,APOB
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.00556125718932749	-5.19193108309098	48	5	0.0203252032520325	246	10287	2041,2049,2042,2051,2044	EPHA1,EPHB3,EPHA3,EPHB6,EPHA5
R-HSA-5173105	O-linked glycosylation	0.00595015452936016	-5.12433808844081	114	8	0.032520325203252	246	10287	256435,10417,4589,157869,374907,9719,7057,143662	ST6GALNAC3,SPON2,MUC7,SBSPON,B3GNT8,ADAMTSL2,THBS1,MUC15
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.00600742154917597	-5.11475964925274	16	3	0.0121951219512195	246	10287	338,948,929	APOB,CD36,CD14
R-HSA-5576891	Cardiac conduction	0.00700488143890026	-4.96114802454693	142	9	0.0365853658536585	246	10287	6326,60598,482,6327,6329,89822,775,816,6546	SCN2A,KCNK15,ATP1B2,SCN2B,SCN4A,KCNK17,CACNA1C,CAMK2B,SLC8A1
R-HSA-211859	Biological oxidations	0.00706935508612383	-4.95198602160434	222	12	0.0487804878048781	246	10287	216,125,126,2946,127,66002,2326,64757,5740,130,51302,2327	ALDH1A1,ADH1B,ADH1C,GSTM2,ADH4,CYP4F12,FMO1,MARC1,PTGIS,ADH6,CYP39A1,FMO2
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.0071673954317121	-4.93821294954064	17	3	0.0121951219512195	246	10287	2891,2905,816	GRIA2,GRIN2C,CAMK2B
R-HSA-8851907	MET activates PI3K/AKT signaling	0.00801758966427858	-4.82611744288874	6	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0084252582286685	-4.77652115292636	34	4	0.016260162601626	246	10287	10398,2041,2044,2042	MYL9,EPHA1,EPHA5,EPHA3
R-HSA-390522	Striated Muscle Contraction	0.0084252582286685	-4.77652115292636	34	4	0.016260162601626	246	10287	7140,7136,4632,4634	TNNT3,TNNI2,MYL1,MYL3
R-HSA-418457	cGMP effects	0.00845092667491966	-4.77347917795493	18	3	0.0121951219512195	246	10287	5593,5136,8654	PRKG2,PDE1A,PDE5A
R-HSA-109582	Hemostasis	0.00899524381948961	-4.71105930583365	632	25	0.101626016260163	246	10287	2162,285,5624,2149,5295,139189,7057,113220,3798,5593,2147,948,482,2625,23539,5023,4778,4352,2788,8654,9127,6546,5136,6382,338	F13A1,ANGPT2,PROC,F2R,PIK3R1,DGKK,THBS1,KIF12,KIF5A,PRKG2,F2,CD36,ATP1B2,GATA3,SLC16A8,P2RX1,NFE2,MPL,GNG7,PDE5A,P2RX6,SLC8A1,PDE1A,SDC1,APOB
R-HSA-112316	Neuronal System	0.00965286171456859	-4.64050085686122	349	16	0.0650406504065041	246	10287	3739,3764,89822,2036,9256,83988,7881,127833,2891,3787,2911,816,2905,2788,5330,107	KCNA4,KCNJ8,KCNK17,EPB41L1,TSPOAP1,NCALD,KCNAB1,SYT2,GRIA2,KCNS1,GRM1,CAMK2B,GRIN2C,GNG7,PLCB2,ADCY1
R-HSA-445355	Smooth Muscle Contraction	0.010311599545476	-4.574485847936	36	4	0.016260162601626	246	10287	25802,10398,93408,4638	LMOD1,MYL9,MYL10,MYLK
R-HSA-1430728	Metabolism	0.0106448987640024	-4.54267449087427	2158	67	0.272357723577236	246	10287	338,2173,33,10840,2327,5260,5740,117245,8908,66002,948,130,51196,2326,7351,165679,1757,7069,55825,5169,51302,26289,5593,1490,5224,29881,2593,2946,51171,374569,5295,5167,1149,64757,11001,5166,127,151742,415,375775,2788,216,5330,760,107,4958,5053,23539,2875,125,126,129807,113026,4948,3158,6382,54511,57571,147323,788,122618,775,54,5105,51477,5244,162466	APOB,FABP7,ACADL,ALDH1L1,FMO2,PHKG1,PTGIS,PLAAT5,GYG2,CYP4F12,CD36,ADH6,PLCE1,FMO1,UCP2,SPTSSB,SARDH,THRSP,PECR,ENPP3,CYP39A1,AK5,PRKG2,CCN2,PGAM2,NPC1L1,GAMT,GSTM2,HSD17B14,ASPG,PIK3R1,ENPP1,CIDEA,MARC1,SLC27A2,PDK4,ADH4,PPM1L,ARSE,PNPLA7,GNG7,ALDH1A1,PLCB2,CA2,ADCY1,OMD,PAH,SLC16A8,GPT,ADH1B,ADH1C,NEU4,PLCD3,OCA2,HMGCS2,SDC1,HMGCLL1,CARNS1,STARD6,SLC25A20,PLD4,CACNA1C,ACP5,PCK1,ISYNA1,ABCB4,PHOSPHO1
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.0110484803508496	-4.50546238528577	7	2	0.00813008130081301	246	10287	5167,54	ENPP1,ACP5
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.0113492249928418	-4.47860581995509	37	4	0.016260162601626	246	10287	10417,9719,7057,157869	SPON2,ADAMTSL2,THBS1,SBSPON
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.0136205045254026	-4.29617893596574	39	4	0.016260162601626	246	10287	2162,5624,2149,2147	F13A1,PROC,F2R,F2
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.0136205045254026	-4.29617893596574	39	4	0.016260162601626	246	10287	9719,10417,157869,7057	ADAMTSL2,SPON2,SBSPON,THBS1
R-HSA-77111	Synthesis of Ketone Bodies	0.0145005901509191	-4.23356593032044	8	2	0.00813008130081301	246	10287	3158,54511	HMGCS2,HMGCLL1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.0161616893262221	-4.12511169383911	41	4	0.016260162601626	246	10287	816,2905,107,2891	CAMK2B,GRIN2C,ADCY1,GRIA2
R-HSA-202733	Cell surface interactions at the vascular wall	0.0163139046071734	-4.11573749141927	136	8	0.032520325203252	246	10287	23539,285,5624,5295,338,482,6382,2147	SLC16A8,ANGPT2,PROC,PIK3R1,APOB,ATP1B2,SDC1,F2
R-HSA-5654695	PI-3K cascade:FGFR2	0.0168028532267268	-4.08620657206903	23	3	0.0121951219512195	246	10287	5295,2252,2549	PIK3R1,FGF7,GAB1
R-HSA-5365859	RA biosynthesis pathway	0.0168028532267268	-4.08620657206903	23	3	0.0121951219512195	246	10287	126,216,127	ADH1C,ALDH1A1,ADH4
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.0183522068288448	-3.99800544856028	9	2	0.00813008130081301	246	10287	2147,5624	F2,PROC
R-HSA-74182	Ketone body metabolism	0.0183522068288448	-3.99800544856028	9	2	0.00813008130081301	246	10287	54511,3158	HMGCLL1,HMGCS2
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0188709457042242	-3.97013180404645	24	3	0.0121951219512195	246	10287	8654,5136,5593	PDE5A,PDE1A,PRKG2
R-HSA-5362517	Signaling by Retinoic Acid	0.0189818562435386	-3.96427169060677	43	4	0.016260162601626	246	10287	216,126,5166,127	ALDH1A1,ADH1C,PDK4,ADH4
R-HSA-977068	Termination of O-glycan biosynthesis	0.0210736282402422	-3.8597328666436	25	3	0.0121951219512195	246	10287	143662,256435,4589	MUC15,ST6GALNAC3,MUC7
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.0225824084202326	-3.79058406429079	10	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-168799	Neurotoxicity of clostridium toxins	0.0225824084202326	-3.79058406429079	10	2	0.00813008130081301	246	10287	127833,9899	SYT2,SV2B
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.0225824084202326	-3.79058406429079	10	2	0.00813008130081301	246	10287	2147,5624	F2,PROC
R-HSA-159740	Gamma-carboxylation of protein precursors	0.0225824084202326	-3.79058406429079	10	2	0.00813008130081301	246	10287	5624,2147	PROC,F2
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.0238871483045346	-3.73441469251588	146	8	0.032520325203252	246	10287	83988,2891,5330,2036,107,2788,816,2905	NCALD,GRIA2,PLCB2,EPB41L1,ADCY1,GNG7,CAMK2B,GRIN2C
R-HSA-418555	G alpha (s) signalling events	0.0238871483045346	-3.73441469251588	146	8	0.032520325203252	246	10287	27115,8622,2788,5136,7432,5745,107,10268	PDE7B,PDE8B,GNG7,PDE1A,VIP,PTH1R,ADCY1,RAMP3
R-HSA-2682334	EPH-Ephrin signaling	0.02614801466878	-3.6439820122413	95	6	0.024390243902439	246	10287	2042,2051,2044,2049,2041,10398	EPHA3,EPHB6,EPHA5,EPHB3,EPHA1,MYL9
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0271710381075202	-3.60560364841511	11	2	0.00813008130081301	246	10287	948,929	CD36,CD14
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.0271710381075202	-3.60560364841511	11	2	0.00813008130081301	246	10287	2147,5624	F2,PROC
R-HSA-5655291	Signaling by FGFR4 in disease	0.0271710381075202	-3.60560364841511	11	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0271710381075202	-3.60560364841511	11	2	0.00813008130081301	246	10287	7069,788	THRSP,SLC25A20
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0271710381075202	-3.60560364841511	11	2	0.00813008130081301	246	10287	948,929	CD36,CD14
R-HSA-983712	Ion channel transport	0.0285903377504865	-3.5546864591295	209	10	0.040650406504065	246	10287	8001,10396,41,1188,79895,121601,22802,55283,482,816	GLRA3,ATP8A1,ASIC1,CLCNKB,ATP8B4,ANO4,CLCA4,MCOLN3,ATP1B2,CAMK2B
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0317389283829306	-3.45021132680637	813	28	0.113821138211382	246	10287	5295,3158,5244,165679,162466,1149,1490,948,29881,129807,51171,51302,5740,788,122618,117245,11001,2173,338,1757,54511,7069,147323,415,151742,375775,55825,33	PIK3R1,HMGCS2,ABCB4,SPTSSB,PHOSPHO1,CIDEA,CCN2,CD36,NPC1L1,NEU4,HSD17B14,CYP39A1,PTGIS,SLC25A20,PLD4,PLAAT5,SLC27A2,FABP7,APOB,SARDH,HMGCLL1,THRSP,STARD6,ARSE,PPM1L,PNPLA7,PECR,ACADL
R-HSA-211979	Eicosanoids	0.0320986798290567	-3.43894037651256	12	2	0.00813008130081301	246	10287	66002,5740	CYP4F12,PTGIS
R-HSA-1296071	Potassium Channels	0.0325467068961953	-3.42507908606945	100	6	0.024390243902439	246	10287	2788,7881,3787,3764,3739,89822	GNG7,KCNAB1,KCNS1,KCNJ8,KCNA4,KCNK17
R-HSA-5654696	Downstream signaling of activated FGFR2	0.0341055541063789	-3.37829503093578	30	3	0.0121951219512195	246	10287	2252,5295,2549	FGF7,PIK3R1,GAB1
R-HSA-445717	Aquaporin-mediated transport	0.0353017647864101	-3.34382232234325	52	4	0.016260162601626	246	10287	2788,360,107,364	GNG7,AQP3,ADCY1,AQP7
R-HSA-418360	Platelet calcium homeostasis	0.0371121210543241	-3.29381164967328	31	3	0.0121951219512195	246	10287	5023,6546,9127	P2RX1,SLC8A1,P2RX6
R-HSA-5339562	Uptake and actions of bacterial toxins	0.0371121210543241	-3.29381164967328	31	3	0.0121951219512195	246	10287	5608,9899,127833	MAP2K6,SV2B,SYT2
R-HSA-2029481	FCGR activation	0.0373466346109383	-3.28751247558774	13	2	0.00813008130081301	246	10287	2214,2209	FCGR3A,FCGR1A
R-HSA-432047	Passive transport by Aquaporins	0.0373466346109383	-3.28751247558774	13	2	0.00813008130081301	246	10287	360,364	AQP3,AQP7
R-HSA-425561	Sodium/Calcium exchangers	0.0373466346109383	-3.28751247558774	13	2	0.00813008130081301	246	10287	25769,6546	SLC24A2,SLC8A1
R-HSA-422475	Axon guidance	0.0397900427322408	-3.22413858059965	549	20	0.0813008130081301	246	10287	2051,2042,2252,775,6329,2549,2041,10398,2044,54209,3815,6326,5295,2905,816,6327,55740,2049,288,4684	EPHB6,EPHA3,FGF7,CACNA1C,SCN4A,GAB1,EPHA1,MYL9,EPHA5,TREM2,KIT,SCN2A,PIK3R1,GRIN2C,CAMK2B,SCN2B,ENAH,EPHB3,ANK3,NCAM1
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.0402498886886892	-3.21264804061979	32	3	0.0121951219512195	246	10287	2788,2149,2147	GNG7,F2R,F2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.0402498886886892	-3.21264804061979	32	3	0.0121951219512195	246	10287	2891,816,2036	GRIA2,CAMK2B,EPB41L1
R-HSA-399719	Trafficking of AMPA receptors	0.0402498886886892	-3.21264804061979	32	3	0.0121951219512195	246	10287	2891,2036,816	GRIA2,EPB41L1,CAMK2B
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0402498886886892	-3.21264804061979	32	3	0.0121951219512195	246	10287	5330,83988,2788	PLCB2,NCALD,GNG7
R-HSA-416476	G alpha (q) signalling events	0.0410551234741315	-3.19283964029622	192	9	0.0365853658536585	246	10287	886,27334,5295,5330,139189,2149,2147,2911,2788	CCKAR,P2RY10,PIK3R1,PLCB2,DGKK,F2R,F2,GRM1,GNG7
R-HSA-425407	SLC-mediated transmembrane transport	0.04296618276193	-3.14734192009754	287	12	0.0487804878048781	246	10287	6546,6563,6508,53919,55867,30061,25769,23539,10991,2030,55089,5172	SLC8A1,SLC14A1,SLC4A3,SLCO1C1,SLC22A11,SLC40A1,SLC24A2,SLC16A8,SLC38A3,SLC29A1,SLC38A4,SLC26A4
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.0430938070339389	-3.14437598050427	107	6	0.024390243902439	246	10287	6546,25769,5172,55089,6508,10991	SLC8A1,SLC24A2,SLC26A4,SLC38A4,SLC4A3,SLC38A3
R-HSA-4085001	Sialic acid metabolism	0.0435175322626985	-3.13459138156471	33	3	0.0121951219512195	246	10287	256435,338596,129807	ST6GALNAC3,ST8SIA6,NEU4
R-HSA-500792	GPCR ligand binding	0.0441008663815197	-3.12127585088286	453	17	0.0691056910569106	246	10287	7504,8325,886,2359,2788,51554,2911,3549,80835,10268,2149,27334,5745,6755,4987,4935,2147	XK,FZD8,CCKAR,FPR3,GNG7,ACKR4,GRM1,IHH,TAS1R1,RAMP3,F2R,P2RY10,PTH1R,SSTR5,OPRL1,GPR143,F2
R-HSA-192105	Synthesis of bile acids and bile salts	0.0469135587810924	-3.05944854550113	34	3	0.0121951219512195	246	10287	11001,51302,5740	SLC27A2,CYP39A1,PTGIS
R-HSA-3000178	ECM proteoglycans	0.0470209593112744	-3.05716183388194	57	4	0.016260162601626	246	10287	4684,1758,54829,7143	NCAM1,DMP1,ASPN,TNR
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.0472577602240924	-3.05213840098097	2	1	0.0040650406504065	246	10287	929	CD14
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.0472577602240924	-3.05213840098097	2	1	0.0040650406504065	246	10287	364	AQP7
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.0472577602240924	-3.05213840098097	2	1	0.0040650406504065	246	10287	5740	PTGIS
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.0472577602240924	-3.05213840098097	2	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.0472577602240924	-3.05213840098097	2	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.0472577602240924	-3.05213840098097	2	1	0.0040650406504065	246	10287	89822	KCNK17
R-HSA-936837	Ion transport by P-type ATPases	0.0495942765975406	-3.00387984308795	58	4	0.016260162601626	246	10287	10396,79895,816,482	ATP8A1,ATP8B4,CAMK2B,ATP1B2
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.0495942765975406	-3.00387984308795	58	4	0.016260162601626	246	10287	127833,2036,2905,2911	SYT2,EPB41L1,GRIN2C,GRM1
R-HSA-1474244	Extracellular matrix organization	0.0520978149912613	-2.95463226984965	296	12	0.0487804878048781	246	10287	4684,1758,54829,7143,11131,50859,81578,8200,827,6382,4237,7057	NCAM1,DMP1,ASPN,TNR,CAPN11,SPOCK3,COL21A1,GDF5,CAPN6,SDC1,MFAP2,THBS1
R-HSA-111885	Opioid Signalling	0.0526772610430409	-2.94357139580797	85	5	0.0203252032520325	246	10287	107,5330,2788,5136,84152	ADCY1,PLCB2,GNG7,PDE1A,PPP1R1B
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.0548356664098732	-2.90341444984166	16	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0548356664098732	-2.90341444984166	16	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.0548356664098732	-2.90341444984166	16	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-438064	Post NMDA receptor activation events	0.0578547385082139	-2.84981991844257	37	3	0.0121951219512195	246	10287	2905,816,107	GRIN2C,CAMK2B,ADCY1
R-HSA-162582	Signal Transduction	0.058933215593639	-2.83135041529419	2548	72	0.292682926829268	246	10287	6017,6755,4987,2252,2670,84894,144165,4638,3249,2359,400581,3549,2905,80835,338,115703,340419,10398,2549,54763,2149,5295,3815,2735,5745,9241,57449,5593,55553,80310,3714,4684,2619,10811,64399,10268,56656,7432,27334,57569,80004,126,7057,1124,4935,343637,5330,107,5136,2788,216,816,5166,127,22943,80319,8549,139189,401541,84033,8622,2147,3798,27115,7504,84152,8325,886,64388,6382,2911,51554	RLBP1,SSTR5,OPRL1,FGF7,GFAP,LINGO1,PRICKLE1,MYLK,HPN,FPR3,GRAPL,IHH,GRIN2C,TAS1R1,APOB,ARHGAP33,RSPO2,MYL9,GAB1,ROPN1,F2R,PIK3R1,KIT,GLI1,PTH1R,NOG,PLEKHG5,PRKG2,SOX6,PDGFD,JAG2,NCAM1,GAS1,NOXA1,HHIP,RAMP3,OR2S2,VIP,P2RY10,ARHGAP20,ESRP2,ADH1C,THBS1,CHN2,GPR143,RSPO4,PLCB2,ADCY1,PDE1A,GNG7,ALDH1A1,CAMK2B,PDK4,ADH4,DKK1,CXXC4,LGR5,DGKK,CENPP,OBSCN,PDE8B,F2,KIF5A,PDE7B,XK,PPP1R1B,FZD8,CCKAR,GREM2,SDC1,GRM1,ACKR4
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	2905,816	GRIN2C,CAMK2B
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	8908,5260	GYG2,PHKG1
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	9127,5023	P2RX6,P2RX1
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	4589,143662	MUC7,MUC15
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	5167,5169	ENPP1,ENPP3
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	4589,143662	MUC7,MUC15
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.0611914358754266	-2.79374803593194	17	2	0.00813008130081301	246	10287	4589,143662	MUC7,MUC15
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.0617464235862058	-2.78471922278364	38	3	0.0121951219512195	246	10287	6648,50507,2878	SOD2,NOX4,GPX3
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.065756916840124	-2.72179041436796	39	3	0.0121951219512195	246	10287	2147,5624,415	F2,PROC,ARSE
R-HSA-210993	Tie2 Signaling	0.0677839995251624	-2.69142910709113	18	2	0.00813008130081301	246	10287	285,5295	ANGPT2,PIK3R1
R-HSA-5654710	PI-3K cascade:FGFR3	0.0677839995251624	-2.69142910709113	18	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-5635838	Activation of SMO	0.0677839995251624	-2.69142910709113	18	2	0.00813008130081301	246	10287	3549,2619	IHH,GAS1
R-HSA-373080	Class B/2 (Secretin family receptors)	0.0692676821297323	-2.66977682889433	92	5	0.0203252032520325	246	10287	5745,8325,3549,10268,2788	PTH1R,FZD8,IHH,RAMP3,GNG7
R-HSA-913709	O-linked glycosylation of mucins	0.0697205814360609	-2.6632597187773	65	4	0.016260162601626	246	10287	143662,4589,374907,256435	MUC15,MUC7,B3GNT8,ST6GALNAC3
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0697205814360609	-2.6632597187773	65	4	0.016260162601626	246	10287	5295,2252,3815,2549	PIK3R1,FGF7,KIT,GAB1
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	57134	MAN1C1
R-HSA-5357572	Lysosomal glycogen catabolism	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	2735	GLI1
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	9899	SV2B
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	3549	IHH
R-HSA-265473	Trafficking of dietary sterols	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	29881	NPC1L1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	127833	SYT2
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.070045761292091	-2.65860651777879	3	1	0.0040650406504065	246	10287	33	ACADL
R-HSA-5576886	Phase 4 - resting membrane potential	0.0745985018276999	-2.59563485471269	19	2	0.00813008130081301	246	10287	60598,89822	KCNK15,KCNK17
R-HSA-3928664	Ephrin signaling	0.0745985018276999	-2.59563485471269	19	2	0.00813008130081301	246	10287	2049,2051	EPHB3,EPHB6
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.0745985018276999	-2.59563485471269	19	2	0.00813008130081301	246	10287	2905,816	GRIN2C,CAMK2B
R-HSA-112315	Transmission across Chemical Synapses	0.0765112142125115	-2.57031795787984	217	9	0.0365853658536585	246	10287	816,2905,2788,5330,2036,107,9256,83988,2891	CAMK2B,GRIN2C,GNG7,PLCB2,EPB41L1,ADCY1,TSPOAP1,NCALD,GRIA2
R-HSA-5654720	PI-3K cascade:FGFR4	0.0816206572354687	-2.50567289665429	20	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.0816206572354687	-2.50567289665429	20	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-1643713	Signaling by EGFR in Cancer	0.0816206572354687	-2.50567289665429	20	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0816206572354687	-2.50567289665429	20	2	0.00813008130081301	246	10287	5330,2788	PLCB2,GNG7
R-HSA-3000170	Syndecan interactions	0.0816206572354687	-2.50567289665429	20	2	0.00813008130081301	246	10287	6382,7057	SDC1,THBS1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.0816206572354687	-2.50567289665429	20	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-375276	Peptide ligand-binding receptors	0.081851589616163	-2.50284755426423	188	8	0.032520325203252	246	10287	4987,6755,51554,2147,2149,7504,2359,886	OPRL1,SSTR5,ACKR4,F2,F2R,XK,FPR3,CCKAR
R-HSA-194068	Bile acid and bile salt metabolism	0.0829403968270235	-2.48963303966819	43	3	0.0121951219512195	246	10287	11001,51302,5740	SLC27A2,CYP39A1,PTGIS
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.0829403968270235	-2.48963303966819	43	3	0.0121951219512195	246	10287	2788,360,107	GNG7,AQP3,ADCY1
R-HSA-5655253	Signaling by FGFR2 in disease	0.0829403968270235	-2.48963303966819	43	3	0.0121951219512195	246	10287	2549,5295,2252	GAB1,PIK3R1,FGF7
R-HSA-1296072	Voltage gated Potassium channels	0.0875092773450391	-2.43601046443857	44	3	0.0121951219512195	246	10287	7881,3787,3739	KCNAB1,KCNS1,KCNA4
R-HSA-500657	Presynaptic function of Kainate receptors	0.088836731589041	-2.42095507049038	21	2	0.00813008130081301	246	10287	5330,2788	PLCB2,GNG7
R-HSA-5654689	PI-3K cascade:FGFR1	0.088836731589041	-2.42095507049038	21	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.0922908743532775	-2.38281001177318	4	1	0.0040650406504065	246	10287	9899	SV2B
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.0922908743532775	-2.38281001177318	4	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-1296025	ATP sensitive Potassium channels	0.0922908743532775	-2.38281001177318	4	1	0.0040650406504065	246	10287	3764	KCNJ8
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.0922908743532775	-2.38281001177318	4	1	0.0040650406504065	246	10287	10370	CITED2
R-HSA-399710	Activation of AMPA receptors	0.0922908743532775	-2.38281001177318	4	1	0.0040650406504065	246	10287	2891	GRIA2
R-HSA-3000497	Scavenging by Class H Receptors	0.0922908743532775	-2.38281001177318	4	1	0.0040650406504065	246	10287	338	APOB
R-HSA-6794362	Protein-protein interactions at synapses	0.0934152802505286	-2.37070034701565	72	4	0.016260162601626	246	10287	2036,2905,2911,127833	EPB41L1,GRIN2C,GRM1,SYT2
R-HSA-373760	L1CAM interactions	0.0943541093210038	-2.36070045410433	101	5	0.0203252032520325	246	10287	6326,6329,6327,4684,288	SCN2A,SCN4A,SCN2B,NCAM1,ANK3
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.09623352411225	-2.34097749852142	22	2	0.00813008130081301	246	10287	2147,5624	F2,PROC
R-HSA-5655332	Signaling by FGFR3 in disease	0.09623352411225	-2.34097749852142	22	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.09623352411225	-2.34097749852142	22	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-112043	PLC beta mediated events	0.101829177187884	-2.28445860308374	47	3	0.0121951219512195	246	10287	5136,107,5330	PDE1A,ADCY1,PLCB2
R-HSA-2672351	Stimuli-sensing channels	0.103622943218331	-2.26699651403892	104	5	0.0203252032520325	246	10287	1188,41,55283,22802,121601	CLCNKB,ASIC1,MCOLN3,CLCA4,ANO4
R-HSA-5627123	RHO GTPases activate PAKs	0.103798349911747	-2.26530520518068	23	2	0.00813008130081301	246	10287	4638,10398	MYLK,MYL9
R-HSA-5654738	Signaling by FGFR2	0.104598587340472	-2.25762523279173	75	4	0.016260162601626	246	10287	80004,2549,5295,2252	ESRP2,GAB1,PIK3R1,FGF7
R-HSA-112040	G-protein mediated events	0.10679776386522	-2.23681829026681	48	3	0.0121951219512195	246	10287	107,5330,5136	ADCY1,PLCB2,PDE1A
R-HSA-201451	Signaling by BMP	0.111519023021499	-2.19356009257592	24	2	0.00813008130081301	246	10287	64388,9241	GREM2,NOG
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.111519023021499	-2.19356009257592	24	2	0.00813008130081301	246	10287	929,948	CD14,CD36
R-HSA-5260271	Diseases of Immune System	0.111519023021499	-2.19356009257592	24	2	0.00813008130081301	246	10287	929,948	CD14,CD36
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.111519023021499	-2.19356009257592	24	2	0.00813008130081301	246	10287	5740,11001	PTGIS,SLC27A2
R-HSA-5662702	Melanin biosynthesis	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	4948	OCA2
R-HSA-561048	Organic anion transport	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	55867	SLC22A11
R-HSA-167826	The fatty acid cycling model	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	7351	UCP2
R-HSA-167827	The proton buffering model	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	7351	UCP2
R-HSA-70350	Fructose catabolism	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	216	ALDH1A1
R-HSA-8852405	Signaling by MST1	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	3249	HPN
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	7351	UCP2
R-HSA-389599	Alpha-oxidation of phytanate	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	11001	SLC27A2
R-HSA-8865999	MET activates PTPN11	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	2549	GAB1
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	9899	SV2B
R-HSA-2161541	Abacavir metabolism	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	5105	PCK1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	57134	MAN1C1
R-HSA-8866423	VLDL biosynthesis	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	338	APOB
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	33	ACADL
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.114005981317312	-2.17150436426831	5	1	0.0040650406504065	246	10287	9899	SV2B
R-HSA-5654708	Downstream signaling of activated FGFR3	0.1193838399592	-2.12541143090872	25	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-397795	G-protein beta:gamma signalling	0.122250008946372	-2.1016870774462	51	3	0.0121951219512195	246	10287	5330,5295,2788	PLCB2,PIK3R1,GNG7
R-HSA-196854	Metabolism of vitamins and cofactors	0.123812466308356	-2.08898722664168	174	7	0.0284552845528455	246	10287	5169,10840,54,5167,6382,338,5740	ENPP3,ALDH1L1,ACP5,ENPP1,SDC1,APOB,PTGIS
R-HSA-6785807	Interleukin-4 and 13 signaling	0.12691557803116	-2.0642331534732	111	5	0.0203252032520325	246	10287	948,2625,6097,5295,2162	CD36,GATA3,RORC,PIK3R1,F13A1
R-HSA-210991	Basigin interactions	0.127381563769965	-2.06056825769753	26	2	0.00813008130081301	246	10287	23539,482	SLC16A8,ATP1B2
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.127381563769965	-2.06056825769753	26	2	0.00813008130081301	246	10287	6382,4958	SDC1,OMD
R-HSA-70326	Glucose metabolism	0.128674472419357	-2.05046953355386	81	4	0.016260162601626	246	10287	8908,5260,5224,5105	GYG2,PHKG1,PGAM2,PCK1
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	80319	CXXC4
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	22943	DKK1
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	6017	RLBP1
R-HSA-193144	Estrogen biosynthesis	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	51171	HSD17B14
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	33	ACADL
R-HSA-6798163	Choline catabolism	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	1757	SARDH
R-HSA-111957	Cam-PDE 1 activation	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	5136	PDE1A
R-HSA-6806942	MET Receptor Activation	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	3249	HPN
R-HSA-5690714	CD22 mediated BCR regulation	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	974	CD79B
R-HSA-3000484	Scavenging by Class F Receptors	0.135203659648618	-2.00097304733268	6	1	0.0040650406504065	246	10287	338	APOB
R-HSA-5654716	Downstream signaling of activated FGFR4	0.135501408559986	-1.99877324343976	27	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-5621480	Dectin-2 family	0.143733024493715	-1.93979769675641	28	2	0.00813008130081301	246	10287	143662,4589	MUC15,MUC7
R-HSA-111933	Calmodulin induced events	0.143733024493715	-1.93979769675641	28	2	0.00813008130081301	246	10287	107,5136	ADCY1,PDE1A
R-HSA-70268	Pyruvate metabolism	0.143733024493715	-1.93979769675641	28	2	0.00813008130081301	246	10287	5166,23539	PDK4,SLC16A8
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.143733024493715	-1.93979769675641	28	2	0.00813008130081301	246	10287	2788,775	GNG7,CACNA1C
R-HSA-111997	CaM pathway	0.143733024493715	-1.93979769675641	28	2	0.00813008130081301	246	10287	107,5136	ADCY1,PDE1A
R-HSA-211976	Endogenous sterols	0.143733024493715	-1.93979769675641	28	2	0.00813008130081301	246	10287	5740,51302	PTGIS,CYP39A1
R-HSA-5578775	Ion homeostasis	0.149652677964303	-1.89943814999354	56	3	0.0121951219512195	246	10287	6546,482,816	SLC8A1,ATP1B2,CAMK2B
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.150331678213252	-1.89491123787612	86	4	0.016260162601626	246	10287	5295,2209,2214,122618	PIK3R1,FCGR1A,FCGR3A,PLD4
R-HSA-5632684	Hedgehog 'on' state	0.150331678213252	-1.89491123787612	86	4	0.016260162601626	246	10287	64399,2619,3549,2735	HHIP,GAS1,IHH,GLI1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.152066483242557	-1.88343746400921	29	2	0.00813008130081301	246	10287	2905,816	GRIN2C,CAMK2B
R-HSA-390918	Peroxisomal lipid metabolism	0.152066483242557	-1.88343746400921	29	2	0.00813008130081301	246	10287	55825,11001	PECR,SLC27A2
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.154822235228517	-1.86547768971441	87	4	0.016260162601626	246	10287	2549,2252,3815,5295	GAB1,FGF7,KIT,PIK3R1
R-HSA-6814848	Glycerophospholipid catabolism	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	375775	PNPLA7
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-3656225	Defective CHST6 causes MCDC1	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	4958	OMD
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	2030	SLC29A1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	23539	SLC16A8
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-5652084	Fructose metabolism	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	216	ALDH1A1
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	4958	OMD
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.155896189532397	-1.85856494495927	7	1	0.0040650406504065	246	10287	4958	OMD
R-HSA-416482	G alpha (12/13) signalling events	0.159362823586732	-1.83657176701258	88	4	0.016260162601626	246	10287	2788,57449,84033,5295	GNG7,PLEKHG5,OBSCN,PIK3R1
R-HSA-111996	Ca-dependent events	0.160492263893359	-1.82950953761511	30	2	0.00813008130081301	246	10287	5136,107	PDE1A,ADCY1
R-HSA-190236	Signaling by FGFR	0.163952127234191	-1.8081808008797	89	4	0.016260162601626	246	10287	2549,80004,2252,5295	GAB1,ESRP2,FGF7,PIK3R1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.167821471285902	-1.7848545355312	122	5	0.0203252032520325	246	10287	5169,10840,5740,54,5167	ENPP3,ALDH1L1,PTGIS,ACP5,ENPP1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.168588819032577	-1.78029255214618	90	4	0.016260162601626	246	10287	2549,5295,3815,2252	GAB1,PIK3R1,KIT,FGF7
R-HSA-428157	Sphingolipid metabolism	0.168588819032577	-1.78029255214618	90	4	0.016260162601626	246	10287	165679,129807,415,151742	SPTSSB,NEU4,ARSE,PPM1L
R-HSA-352230	Amino acid transport across the plasma membrane	0.169001239266383	-1.77784923114877	31	2	0.00813008130081301	246	10287	10991,55089	SLC38A3,SLC38A4
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.169001239266383	-1.77784923114877	31	2	0.00813008130081301	246	10287	2875,374569	GPT,ASPG
R-HSA-1296065	Inwardly rectifying K+ channels	0.169001239266383	-1.77784923114877	31	2	0.00813008130081301	246	10287	3764,2788	KCNJ8,GNG7
R-HSA-2129379	Molecules associated with elastic fibres	0.169001239266383	-1.77784923114877	31	2	0.00813008130081301	246	10287	8200,4237	GDF5,MFAP2
R-HSA-5654687	Downstream signaling of activated FGFR1	0.169001239266383	-1.77784923114877	31	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.175449850034674	-1.74040203170008	443	14	0.0569105691056911	246	10287	2149,4684,886,27334,5330,139189,5295,3815,2788,816,2147,2905,2911,2252	F2R,NCAM1,CCKAR,P2RY10,PLCB2,DGKK,PIK3R1,KIT,GNG7,CAMK2B,F2,GRIN2C,GRM1,FGF7
R-HSA-70921	Histidine catabolism	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	57571	CARNS1
R-HSA-1483148	Synthesis of PG	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	122618	PLD4
R-HSA-110329	Cleavage of the damaged pyrimidine	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	5330	PLCB2
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	948	CD36
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	3549	IHH
R-HSA-73928	Depyrimidination	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	84894	LINGO1
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	2359	FPR3
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.176095560867777	-1.73672847181714	8	1	0.0040650406504065	246	10287	5330	PLCB2
R-HSA-70263	Gluconeogenesis	0.177584662640198	-1.72830781116112	32	2	0.00813008130081301	246	10287	5105,5224	PCK1,PGAM2
R-HSA-196071	Metabolism of steroid hormones	0.177584662640198	-1.72830781116112	32	2	0.00813008130081301	246	10287	51171,147323	HSD17B14,STARD6
R-HSA-4086398	Ca2+ pathway	0.178802462280552	-1.72147364519352	61	3	0.0121951219512195	246	10287	5593,5330,2788	PRKG2,PLCB2,GNG7
R-HSA-195721	Signaling by Wnt	0.181863717576967	-1.70449767692164	336	11	0.0447154471544715	246	10287	340419,343637,55553,5593,2788,8325,5330,144165,8549,80319,22943	RSPO2,RSPO4,SOX6,PRKG2,GNG7,FZD8,PLCB2,PRICKLE1,LGR5,CXXC4,DKK1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.186234154926206	-1.6807504995632	33	2	0.00813008130081301	246	10287	107,2788	ADCY1,GNG7
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.187582611874015	-1.67353593394446	94	4	0.016260162601626	246	10287	2549,5295,3815,2252	GAB1,PIK3R1,KIT,FGF7
R-HSA-1226099	Signaling by FGFR in disease	0.19087108463698	-1.6561570283611	63	3	0.0121951219512195	246	10287	2549,5295,2252	GAB1,PIK3R1,FGF7
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.19087108463698	-1.6561570283611	63	3	0.0121951219512195	246	10287	338596,129807,256435	ST8SIA6,NEU4,ST6GALNAC3
R-HSA-1489509	DAG and IP3 signaling	0.194941692176683	-1.63505477961068	34	2	0.00813008130081301	246	10287	5136,107	PDE1A,ADCY1
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	54763	ROPN1
R-HSA-193697	p75NTR regulates axonogenesis	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	84894	LINGO1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	8325	FZD8
R-HSA-2453864	Retinoid cycle disease events	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	6017	RLBP1
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	760	CA2
R-HSA-166665	Terminal pathway of complement	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	730	C7
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-2474795	Diseases associated with visual transduction	0.195813480126708	-1.63059270484742	9	1	0.0040650406504065	246	10287	6017	RLBP1
R-HSA-4791275	Signaling by WNT in cancer	0.203699593560376	-1.59110895103671	35	2	0.00813008130081301	246	10287	8325,22943	FZD8,DKK1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.212500509581636	-1.54881089258931	36	2	0.00813008130081301	246	10287	5136,107	PDE1A,ADCY1
R-HSA-167021	PLC-gamma1 signalling	0.212500509581636	-1.54881089258931	36	2	0.00813008130081301	246	10287	5136,107	PDE1A,ADCY1
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-2161522	Abacavir transport and metabolism	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	5105	PCK1
R-HSA-2562578	TRIF-mediated programmed cell death	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	929	CD14
R-HSA-170660	Adenylate cyclase activating pathway	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-427601	Multifunctional anion exchangers	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	5172	SLC26A4
R-HSA-425381	Bicarbonate transporters	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	6508	SLC4A3
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	33	ACADL
R-HSA-3229121	Glycogen storage diseases	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-399997	Acetylcholine regulates insulin secretion	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	5330	PLCB2
R-HSA-419812	Calcitonin-like ligand receptors	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	10268	RAMP3
R-HSA-430116	GP1b-IX-V activation signalling	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-196108	Pregnenolone biosynthesis	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	147323	STARD6
R-HSA-1250342	PI3K events in ERBB4 signaling	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-190377	FGFR2b ligand binding and activation	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-5663084	Diseases of carbohydrate metabolism	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-8875656	MET receptor recycling	0.215061376980823	-1.53683181726511	10	1	0.0040650406504065	246	10287	2549	GAB1
R-HSA-419037	NCAM1 interactions	0.22133741078457	-1.50806699612406	37	2	0.00813008130081301	246	10287	775,4684	CACNA1C,NCAM1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.221868848371947	-1.50566884478438	68	3	0.0121951219512195	246	10287	51302,66002,5740	CYP39A1,CYP4F12,PTGIS
R-HSA-6806834	Signaling by MET	0.228188408676085	-1.47758363742758	69	3	0.0121951219512195	246	10287	3249,5295,2549	HPN,PIK3R1,GAB1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.230203576745668	-1.46879124525786	38	2	0.00813008130081301	246	10287	2147,4352	F2,MPL
R-HSA-5655302	Signaling by FGFR1 in disease	0.230203576745668	-1.46879124525786	38	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-8875555	MET activates RAP1 and RAC1	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	2549	GAB1
R-HSA-1980150	Signaling by NOTCH4	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	51477	ISYNA1
R-HSA-5625970	RHO GTPases activate KTN1	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	3798	KIF5A
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	5053	PAH
R-HSA-1980148	Signaling by NOTCH3	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-71288	Creatine metabolism	0.233850410868909	-1.45307363783548	11	1	0.0040650406504065	246	10287	2593	GAMT
R-HSA-76002	Platelet activation, signaling and aggregation	0.233972412044283	-1.45255206782151	282	9	0.0365853658536585	246	10287	2147,948,2788,7057,5295,139189,4352,2162,2149	F2,CD36,GNG7,THBS1,PIK3R1,DGKK,MPL,F13A1,F2R
R-HSA-5358351	Signaling by Hedgehog	0.234958701877692	-1.44834551697215	138	5	0.0203252032520325	246	10287	107,2735,3549,64399,2619	ADCY1,GLI1,IHH,HHIP,GAS1
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.239092585386404	-1.43090441551143	39	2	0.00813008130081301	246	10287	2911,80835	GRM1,TAS1R1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.239092585386404	-1.43090441551143	39	2	0.00813008130081301	246	10287	974,5295	CD79B,PIK3R1
R-HSA-1643685	Disease	0.239985971982266	-1.42717480742231	859	24	0.0975609756097561	246	10287	6382,3549,5608,9719,143662,8325,3714,4958,9899,157869,8908,2252,929,948,6648,7057,4589,5295,3815,6017,10417,22943,2549,127833	SDC1,IHH,MAP2K6,ADAMTSL2,MUC15,FZD8,JAG2,OMD,SV2B,SBSPON,GYG2,FGF7,CD14,CD36,SOD2,THBS1,MUC7,PIK3R1,KIT,RLBP1,SPON2,DKK1,GAB1,SYT2
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.242514460237301	-1.41669394053785	322	10	0.040650406504065	246	10287	2149,7504,2359,27334,886,4987,6755,4935,51554,2147	F2R,XK,FPR3,P2RY10,CCKAR,OPRL1,SSTR5,GPR143,ACKR4,F2
R-HSA-991365	Activation of GABAB receptors	0.247998302693017	-1.39433337682035	40	2	0.00813008130081301	246	10287	2788,107	GNG7,ADCY1
R-HSA-977444	GABA B receptor activation	0.247998302693017	-1.39433337682035	40	2	0.00813008130081301	246	10287	107,2788	ADCY1,GNG7
R-HSA-5654741	Signaling by FGFR3	0.247998302693017	-1.39433337682035	40	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.247998302693017	-1.39433337682035	40	2	0.00813008130081301	246	10287	53919,2030	SLCO1C1,SLC29A1
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.247998302693017	-1.39433337682035	40	2	0.00813008130081301	246	10287	3815,10370	KIT,CITED2
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.248114333513111	-1.39386561682497	106	4	0.016260162601626	246	10287	23539,6563,30061,55867	SLC16A8,SLC14A1,SLC40A1,SLC22A11
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-417957	P2Y receptors	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	27334	P2RY10
R-HSA-2022857	Keratan sulfate degradation	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	4958	OMD
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	83988	NCALD
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	83988	NCALD
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	5593	PRKG2
R-HSA-879518	Transport of organic anions	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	53919	SLCO1C1
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	10370	CITED2
R-HSA-1296346	Tandem pore domain potassium channels	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	89822	KCNK17
R-HSA-1475029	Reversible hydration of carbon dioxide	0.252191477329234	-1.37756664932433	12	1	0.0040650406504065	246	10287	760	CA2
R-HSA-5654743	Signaling by FGFR4	0.2569148726646	-1.35901048372537	41	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-194840	Rho GTPase cycle	0.257347710466955	-1.35732714949588	143	5	0.0203252032520325	246	10287	57569,84033,57449,1124,115703	ARHGAP20,OBSCN,PLEKHG5,CHN2,ARHGAP33
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.259628221857274	-1.34850458720557	253	8	0.032520325203252	246	10287	33,7069,948,54511,1490,788,3158,5244	ACADL,THRSP,CD36,HMGCLL1,CCN2,SLC25A20,HMGCS2,ABCB4
R-HSA-1566948	Elastic fibre formation	0.265836707648158	-1.32487303972451	42	2	0.00813008130081301	246	10287	8200,4237	GDF5,MFAP2
R-HSA-3928662	EPHB-mediated forward signaling	0.265836707648158	-1.32487303972451	42	2	0.00813008130081301	246	10287	2049,2051	EPHB3,EPHB6
R-HSA-983189	Kinesins	0.265836707648158	-1.32487303972451	42	2	0.00813008130081301	246	10287	113220,3798	KIF12,KIF5A
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	760	CA2
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	10370	CITED2
R-HSA-5210891	Uptake and function of anthrax toxins	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	4137	MAPT
R-HSA-1663150	The activation of arylsulfatases	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	415	ARSE
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	760	CA2
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	2041	EPHA1
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.270095214221892	-1.30898073688222	13	1	0.0040650406504065	246	10287	10811	NOXA1
R-HSA-163685	Integration of energy metabolism	0.274503307531001	-1.29279196881188	111	4	0.016260162601626	246	10287	5330,775,107,2788	PLCB2,CACNA1C,ADCY1,GNG7
R-HSA-1236394	Signaling by ERBB4	0.274758478905139	-1.29186282573731	43	2	0.00813008130081301	246	10287	5295,2670	PIK3R1,GFAP
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.274758478905139	-1.29186282573731	43	2	0.00813008130081301	246	10287	338,948	APOB,CD36
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.28367510755378	-1.25992568316078	44	2	0.00813008130081301	246	10287	5053,57571	PAH,CARNS1
R-HSA-975634	Retinoid metabolism and transport	0.28367510755378	-1.25992568316078	44	2	0.00813008130081301	246	10287	338,6382	APOB,SDC1
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.28367510755378	-1.25992568316078	44	2	0.00813008130081301	246	10287	151742,165679	PPM1L,SPTSSB
R-HSA-3858494	Beta-catenin independent WNT signaling	0.284852148139132	-1.25578501178477	149	5	0.0203252032520325	246	10287	2788,144165,5330,5593,8325	GNG7,PRICKLE1,PLCB2,PRKG2,FZD8
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.286290127976232	-1.25074954886889	78	3	0.0121951219512195	246	10287	256435,129807,338596	ST6GALNAC3,NEU4,ST8SIA6
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.287572007805292	-1.24628198817363	14	1	0.0040650406504065	246	10287	5166	PDK4
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.287572007805292	-1.24628198817363	14	1	0.0040650406504065	246	10287	6546	SLC8A1
R-HSA-1483213	Synthesis of PE	0.287572007805292	-1.24628198817363	14	1	0.0040650406504065	246	10287	162466	PHOSPHO1
R-HSA-186797	Signaling by PDGF	0.289216298726551	-1.24058043230995	376	11	0.0447154471544715	246	10287	2252,816,2905,80310,5136,7057,107,3815,5295,4684,2549	FGF7,CAMK2B,GRIN2C,PDGFD,PDE1A,THBS1,ADCY1,KIT,PIK3R1,NCAM1,GAB1
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.292581755705836	-1.22901114467832	45	2	0.00813008130081301	246	10287	6382,7057	SDC1,THBS1
R-HSA-109704	PI3K Cascade	0.292838176865451	-1.22813511992499	79	3	0.0121951219512195	246	10287	2549,5295,2252	GAB1,PIK3R1,FGF7
R-HSA-73923	Lipid digestion, mobilization, and transport	0.295941871827712	-1.21759222290338	115	4	0.016260162601626	246	10287	29881,1149,2173,338	NPC1L1,CIDEA,FABP7,APOB
R-HSA-422356	Regulation of insulin secretion	0.29939638084293	-1.20598689510263	80	3	0.0121951219512195	246	10287	5330,775,2788	PLCB2,CACNA1C,GNG7
R-HSA-1660662	Glycosphingolipid metabolism	0.301473817954271	-1.19907210587496	46	2	0.00813008130081301	246	10287	415,129807	ARSE,NEU4
R-HSA-168898	Toll-Like Receptors Cascades	0.303491746154	-1.19240086439111	153	5	0.0203252032520325	246	10287	9450,5608,929,948,338	LY86,MAP2K6,CD14,CD36,APOB
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	5740	PTGIS
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-211935	Fatty acids	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	66002	CYP4F12
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	5740	PTGIS
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-975577	N-Glycan antennae elongation	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	338596	ST8SIA6
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	22943	DKK1
R-HSA-3322077	Glycogen synthesis	0.304631998663456	-1.18865079261556	15	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-372790	Signaling by GPCR	0.311699130757513	-1.1657168809278	1299	34	0.138211382113821	246	10287	8325,4684,886,7504,84152,2911,51554,139189,5295,3815,5745,2149,2147,27115,84033,8622,57449,5330,107,2359,3549,816,2905,80835,5136,2788,56656,7432,27334,10268,2252,4935,6755,4987	FZD8,NCAM1,CCKAR,XK,PPP1R1B,GRM1,ACKR4,DGKK,PIK3R1,KIT,PTH1R,F2R,F2,PDE7B,OBSCN,PDE8B,PLEKHG5,PLCB2,ADCY1,FPR3,IHH,CAMK2B,GRIN2C,TAS1R1,PDE1A,GNG7,OR2S2,VIP,P2RY10,RAMP3,FGF7,GPR143,SSTR5,OPRL1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.319196876112303	-1.14194720006996	48	2	0.00813008130081301	246	10287	5295,2788	PIK3R1,GNG7
R-HSA-418597	G alpha (z) signalling events	0.319196876112303	-1.14194720006996	48	2	0.00813008130081301	246	10287	2788,107	GNG7,ADCY1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.321285087477458	-1.13542642701725	16	1	0.0040650406504065	246	10287	27334	P2RY10
R-HSA-549132	Organic cation/anion/zwitterion transport	0.321285087477458	-1.13542642701725	16	1	0.0040650406504065	246	10287	55867	SLC22A11
R-HSA-163615	PKA activation	0.321285087477458	-1.13542642701725	16	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.321285087477458	-1.13542642701725	16	1	0.0040650406504065	246	10287	929	CD14
R-HSA-1433559	Regulation of KIT signaling	0.321285087477458	-1.13542642701725	16	1	0.0040650406504065	246	10287	3815	KIT
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.321285087477458	-1.13542642701725	16	1	0.0040650406504065	246	10287	3815	KIT
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.328019750384236	-1.11468145782473	49	2	0.00813008130081301	246	10287	23539,5166	SLC16A8,PDK4
R-HSA-5654736	Signaling by FGFR1	0.33681178020938	-1.08823102035694	50	2	0.00813008130081301	246	10287	2549,5295	GAB1,PIK3R1
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-5625900	RHO GTPases activate CIT	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	10398	MYL9
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	2891	GRIA2
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	929	CD14
R-HSA-2033519	Activated point mutants of FGFR2	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-164378	PKA activation in glucagon signalling	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	107	ADCY1
R-HSA-432142	Platelet sensitization by LDL	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	338	APOB
R-HSA-140534	Ligand-dependent caspase activation	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	929	CD14
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	9256	TSPOAP1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.337540940713061	-1.08606847021003	17	1	0.0040650406504065	246	10287	10398	MYL9
R-HSA-201681	TCF dependent signaling in response to WNT	0.343027384448765	-1.06994499696004	238	7	0.0284552845528455	246	10287	340419,343637,55553,8325,8549,80319,22943	RSPO2,RSPO4,SOX6,FZD8,LGR5,CXXC4,DKK1
R-HSA-1989781	PPARA activates gene expression	0.344804281182245	-1.06477832384786	124	4	0.016260162601626	246	10287	1490,3158,948,5244	CCN2,HMGCS2,CD36,ABCB4
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.344804281182245	-1.06477832384786	124	4	0.016260162601626	246	10287	4068,2214,54209,2209	SH2D1A,FCGR3A,TREM2,FCGR1A
R-HSA-1227986	Signaling by ERBB2	0.345569403533779	-1.06256177741299	51	2	0.00813008130081301	246	10287	5295,2549	PIK3R1,GAB1
R-HSA-2424491	DAP12 signaling	0.346767666241407	-1.05910027302038	356	10	0.040650406504065	246	10287	5295,3815,107,4684,2549,54209,2905,816,2252,5136	PIK3R1,KIT,ADCY1,NCAM1,GAB1,TREM2,GRIN2C,CAMK2B,FGF7,PDE1A
R-HSA-1257604	PIP3 activates AKT signaling	0.350259285026746	-1.04908158440406	125	4	0.016260162601626	246	10287	5295,3815,2252,2549	PIK3R1,KIT,FGF7,GAB1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	9256	TSPOAP1
R-HSA-197264	Nicotinamide salvaging	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	5740	PTGIS
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-912631	Regulation of signaling by CBL	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-196757	Metabolism of folate and pterines	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	10840	ALDH1L1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	9256	TSPOAP1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	929	CD14
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.353408996072707	-1.04012926364038	18	1	0.0040650406504065	246	10287	225	ABCD2
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.35571532726134	-1.03362451053906	126	4	0.016260162601626	246	10287	948,5608,9450,929	CD36,MAP2K6,LY86,CD14
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.361171330218721	-1.01840283429189	127	4	0.016260162601626	246	10287	3158,948,5244,1490	HMGCS2,CD36,ABCB4,CCN2
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.362968108399614	-1.01344030422527	53	2	0.00813008130081301	246	10287	6382,338	SDC1,APOB
R-HSA-198203	PI3K/AKT activation	0.366626233184414	-1.00341238807773	128	4	0.016260162601626	246	10287	5295,2252,3815,2549	PIK3R1,FGF7,KIT,GAB1
R-HSA-180292	GAB1 signalosome	0.366626233184414	-1.00341238807773	128	4	0.016260162601626	246	10287	5295,3815,2252,2549	PIK3R1,KIT,FGF7,GAB1
R-HSA-416700	Other semaphorin interactions	0.368898467972643	-0.997233827349249	19	1	0.0040650406504065	246	10287	54209	TREM2
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.368898467972643	-0.997233827349249	19	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.368898467972643	-0.997233827349249	19	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.368898467972643	-0.997233827349249	19	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.368898467972643	-0.997233827349249	19	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.372078992615966	-0.988649101509312	129	4	0.016260162601626	246	10287	1757,162466,122618,117245	SARDH,PHOSPHO1,PLD4,PLAAT5
R-HSA-1483257	Phospholipid metabolism	0.375034873396006	-0.980736261612877	207	6	0.024390243902439	246	10287	5295,1757,117245,122618,375775,162466	PIK3R1,SARDH,PLAAT5,PLD4,PNPLA7,PHOSPHO1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.382973993986671	-0.959788192924947	131	4	0.016260162601626	246	10287	3815,2252,5295,2549	KIT,FGF7,PIK3R1,GAB1
R-HSA-190241	FGFR2 ligand binding and activation	0.384018352752641	-0.957064933909821	20	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.384018352752641	-0.957064933909821	20	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.384018352752641	-0.957064933909821	20	1	0.0040650406504065	246	10287	1271	CNTFR
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.384018352752641	-0.957064933909821	20	1	0.0040650406504065	246	10287	2173	FABP7
R-HSA-977443	GABA receptor activation	0.388729434234985	-0.944871719177498	56	2	0.00813008130081301	246	10287	2788,107	GNG7,ADCY1
R-HSA-877300	Interferon gamma signaling	0.391167035320781	-0.938620609911941	94	3	0.0121951219512195	246	10287	2209,4684,816	FCGR1A,NCAM1,CAMK2B
R-HSA-2172127	DAP12 interactions	0.395127475061807	-0.928546844468993	371	10	0.040650406504065	246	10287	54209,2549,4684,5295,3815,107,5136,816,2905,2252	TREM2,GAB1,NCAM1,PIK3R1,KIT,ADCY1,PDE1A,CAMK2B,GRIN2C,FGF7
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.397647393797169	-0.922189611612367	95	3	0.0121951219512195	246	10287	5608,929,948	MAP2K6,CD14,CD36
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.397647393797169	-0.922189611612367	95	3	0.0121951219512195	246	10287	948,5608,929	CD36,MAP2K6,CD14
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.397647393797169	-0.922189611612367	95	3	0.0121951219512195	246	10287	929,5608,948	CD14,MAP2K6,CD36
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.397647393797169	-0.922189611612367	95	3	0.0121951219512195	246	10287	948,929,5608	CD36,CD14,MAP2K6
R-HSA-2024096	HS-GAG degradation	0.398777433811749	-0.919351827721765	21	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-445144	Signal transduction by L1	0.398777433811749	-0.919351827721765	21	1	0.0040650406504065	246	10287	4684	NCAM1
R-HSA-3000480	Scavenging by Class A Receptors	0.398777433811749	-0.919351827721765	21	1	0.0040650406504065	246	10287	338	APOB
R-HSA-8849932	SALM protein interactions at the synapses	0.398777433811749	-0.919351827721765	21	1	0.0040650406504065	246	10287	2905	GRIN2C
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.398777433811749	-0.919351827721765	21	1	0.0040650406504065	246	10287	2147	F2
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.398777433811749	-0.919351827721765	21	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-193704	p75 NTR receptor-mediated signalling	0.410551305736691	-0.890254374375228	97	3	0.0121951219512195	246	10287	57449,84894,84033	PLEKHG5,LINGO1,OBSCN
R-HSA-202131	Metabolism of nitric oxide	0.413184286647144	-0.883861570903256	22	1	0.0040650406504065	246	10287	5593	PRKG2
R-HSA-373753	Nephrin interactions	0.413184286647144	-0.883861570903256	22	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.413184286647144	-0.883861570903256	22	1	0.0040650406504065	246	10287	33	ACADL
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.413184286647144	-0.883861570903256	22	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-203765	eNOS activation and regulation	0.413184286647144	-0.883861570903256	22	1	0.0040650406504065	246	10287	5593	PRKG2
R-HSA-193648	NRAGE signals death through JNK	0.422339126038175	-0.861946671468534	60	2	0.00813008130081301	246	10287	57449,84033	PLEKHG5,OBSCN
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.423370320739289	-0.859508020189212	99	3	0.0121951219512195	246	10287	338,90019,127833	APOB,SYT8,SYT2
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	9256	TSPOAP1
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	6017	RLBP1
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	6648	SOD2
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-428930	Thromboxane signalling through TP receptor	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-389948	PD-1 signaling	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	5133	PDCD1
R-HSA-8855121	VLDL interactions	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	338	APOB
R-HSA-3371571	HSF1-dependent transactivation	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	816	CAMK2B
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-8863678	Neurodegenerative Diseases	0.427247283779663	-0.850392314456235	23	1	0.0040650406504065	246	10287	6648	SOD2
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.43059460617405	-0.842588220433045	61	2	0.00813008130081301	246	10287	2209,2214	FCGR1A,FCGR3A
R-HSA-1236975	Antigen processing-Cross presentation	0.436094048628933	-0.829897351030173	101	3	0.0121951219512195	246	10287	2209,948,929	FCGR1A,CD36,CD14
R-HSA-2187338	Visual phototransduction	0.436094048628933	-0.829897351030173	101	3	0.0121951219512195	246	10287	6017,338,6382	RLBP1,APOB,SDC1
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.440974599462353	-0.818768002785132	24	1	0.0040650406504065	246	10287	10398	MYL9
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.440974599462353	-0.818768002785132	24	1	0.0040650406504065	246	10287	9256	TSPOAP1
R-HSA-171052	LDL-mediated lipid transport	0.440974599462353	-0.818768002785132	24	1	0.0040650406504065	246	10287	338	APOB
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.440974599462353	-0.818768002785132	24	1	0.0040650406504065	246	10287	929	CD14
R-HSA-194315	Signaling by Rho GTPases	0.444160746852124	-0.81156873961173	427	11	0.0447154471544715	246	10287	10398,54763,4638,57569,401541,84033,10811,57449,1124,3798,115703	MYL9,ROPN1,MYLK,ARHGAP20,CENPP,OBSCN,NOXA1,PLEKHG5,CHN2,KIF5A,ARHGAP33
R-HSA-1296041	Activation of G protein gated Potassium channels	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-982772	Growth hormone receptor signaling	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	1154	CISH
R-HSA-1296059	G protein gated Potassium channels	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-3295583	TRP channels	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	55283	MCOLN3
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	26289	AK5
R-HSA-1251985	Nuclear signaling by ERBB4	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	2670	GFAP
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-425410	Metal ion SLC transporters	0.454374214442061	-0.788834159571642	25	1	0.0040650406504065	246	10287	30061	SLC40A1
R-HSA-186763	Downstream signal transduction	0.467189800476903	-0.761019678877436	352	9	0.0365853658536585	246	10287	2905,816,2252,5136,5295,3815,107,4684,2549	GRIN2C,CAMK2B,FGF7,PDE1A,PIK3R1,KIT,ADCY1,NCAM1,GAB1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.467453920465252	-0.760454500961057	26	1	0.0040650406504065	246	10287	338596	ST8SIA6
R-HSA-975298	Ligand-gated ion channel transport	0.467453920465252	-0.760454500961057	26	1	0.0040650406504065	246	10287	8001	GLRA3
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.467453920465252	-0.760454500961057	26	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-8853659	RET signaling	0.468434447778882	-0.758359106455333	270	7	0.0284552845528455	246	10287	4684,3815,2252,2905,816,5295,2549	NCAM1,KIT,FGF7,GRIN2C,CAMK2B,PIK3R1,GAB1
R-HSA-166520	Signalling by NGF	0.470843734262354	-0.753229014404926	477	12	0.0487804878048781	246	10287	5136,57449,84033,2252,2905,816,2549,84894,3815,107,5295,4684	PDE1A,PLEKHG5,OBSCN,FGF7,GRIN2C,CAMK2B,GAB1,LINGO1,KIT,ADCY1,PIK3R1,NCAM1
R-HSA-4608870	Asymmetric localization of PCP proteins	0.478754861439947	-0.736566584095083	67	2	0.00813008130081301	246	10287	8325,144165	FZD8,PRICKLE1
R-HSA-6783589	Interleukin-6 family signaling	0.48022132477701	-0.733508188065605	27	1	0.0040650406504065	246	10287	1271	CNTFR
R-HSA-180024	DARPP-32 events	0.48022132477701	-0.733508188065605	27	1	0.0040650406504065	246	10287	84152	PPP1R1B
R-HSA-400685	Sema4D in semaphorin signaling	0.48022132477701	-0.733508188065605	27	1	0.0040650406504065	246	10287	10398	MYL9
R-HSA-114508	Effects of PIP2 hydrolysis	0.48022132477701	-0.733508188065605	27	1	0.0040650406504065	246	10287	139189	DGKK
R-HSA-977606	Regulation of Complement cascade	0.48022132477701	-0.733508188065605	27	1	0.0040650406504065	246	10287	730	C7
R-HSA-373755	Semaphorin interactions	0.486539286090878	-0.72043762811715	68	2	0.00813008130081301	246	10287	54209,10398	TREM2,MYL9
R-HSA-8856688	Golgi-to-ER retrograde transport	0.491926138480137	-0.709426698800092	110	3	0.0121951219512195	246	10287	3798,5050,113220	KIF5A,PAFAH1B3,KIF12
R-HSA-264876	Insulin processing	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	3798	KIF5A
R-HSA-5576893	Phase 2 - plateau phase	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	775	CACNA1C
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	5050	PAFAH1B3
R-HSA-1483191	Synthesis of PC	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	162466	PHOSPHO1
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	929	CD14
R-HSA-6803529	FGFR2 alternative splicing	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	80004	ESRP2
R-HSA-1266695	Interleukin-7 signaling	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-2022854	Keratan sulfate biosynthesis	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	4958	OMD
R-HSA-174800	Chylomicron-mediated lipid transport	0.492683854413236	-0.707887579578986	28	1	0.0040650406504065	246	10287	338	APOB
R-HSA-388841	Costimulation by the CD28 family	0.494251252569969	-0.704711282650415	69	2	0.00813008130081301	246	10287	5133,5295	PDCD1,PIK3R1
R-HSA-1474228	Degradation of the extracellular matrix	0.497965661568263	-0.697224157009	111	3	0.0121951219512195	246	10287	827,50859,11131	CAPN6,SPOCK3,CAPN11
R-HSA-202040	G-protein activation	0.504848760512774	-0.683496378694228	29	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-375170	CDO in myogenesis	0.504848760512774	-0.683496378694228	29	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.504848760512774	-0.683496378694228	29	1	0.0040650406504065	246	10287	1490	CCN2
R-HSA-196807	Nicotinate metabolism	0.504848760512774	-0.683496378694228	29	1	0.0040650406504065	246	10287	5740	PTGIS
R-HSA-525793	Myogenesis	0.504848760512774	-0.683496378694228	29	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-1482839	Acyl chain remodelling of PE	0.504848760512774	-0.683496378694228	29	1	0.0040650406504065	246	10287	117245	PLAAT5
R-HSA-1266738	Developmental Biology	0.506820310700199	-0.679598754976312	1075	26	0.105691056910569	246	10287	2049,6768,288,4684,11005,3851,55740,6327,816,2905,5608,2044,54209,2549,2041,10398,3815,6326,5295,2051,2042,948,6329,5105,2252,775	EPHB3,ST14,ANK3,NCAM1,SPINK5,KRT4,ENAH,SCN2B,CAMK2B,GRIN2C,MAP2K6,EPHA5,TREM2,GAB1,EPHA1,MYL9,KIT,SCN2A,PIK3R1,EPHB6,EPHA3,CD36,SCN4A,PCK1,FGF7,CACNA1C
R-HSA-177929	Signaling by EGFR	0.507676166343923	-0.677911502499584	364	9	0.0365853658536585	246	10287	2252,2905,816,5136,4684,107,3815,5295,2549	FGF7,GRIN2C,CAMK2B,PDE1A,NCAM1,ADCY1,KIT,PIK3R1,GAB1
R-HSA-6809371	Formation of the cornified envelope	0.509453915128607	-0.674415881580857	71	2	0.00813008130081301	246	10287	11005,6768	SPINK5,ST14
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.515171246155162	-0.663255916783723	156	4	0.016260162601626	246	10287	4778,2625,113220,3798	NFE2,GATA3,KIF12,KIF5A
R-HSA-420092	Glucagon-type ligand receptors	0.5167231224766	-0.660248094396862	30	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.5167231224766	-0.660248094396862	30	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-166054	Activated TLR4 signalling	0.521755643946349	-0.65055591574486	115	3	0.0121951219512195	246	10287	948,929,5608	CD36,CD14,MAP2K6
R-HSA-5663202	Diseases of signal transduction	0.527590471543332	-0.639434918303328	370	9	0.0365853658536585	246	10287	3549,2252,22943,2549,6017,5295,8325,3815,3714	IHH,FGF7,DKK1,GAB1,RLBP1,PIK3R1,FZD8,KIT,JAG2
R-HSA-2022928	HS-GAG biosynthesis	0.528313851920903	-0.638064755354534	31	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-8875878	MET promotes cell motility	0.528313851920903	-0.638064755354534	31	1	0.0040650406504065	246	10287	2549	GAB1
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.528313851920903	-0.638064755354534	31	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-1839124	FGFR1 mutant receptor activation	0.528313851920903	-0.638064755354534	31	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-168638	NOD1/2 Signaling Pathway	0.539627696743418	-0.616875827679245	32	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.539627696743418	-0.616875827679245	32	1	0.0040650406504065	246	10287	50859	SPOCK3
R-HSA-70171	Glycolysis	0.539627696743418	-0.616875827679245	32	1	0.0040650406504065	246	10287	5224	PGAM2
R-HSA-376176	Signaling by Robo receptor	0.539627696743418	-0.616875827679245	32	1	0.0040650406504065	246	10287	55740	ENAH
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.546133222956391	-0.604892334911296	76	2	0.00813008130081301	246	10287	57449,84033	PLEKHG5,OBSCN
R-HSA-1839126	FGFR2 mutant receptor activation	0.550671244925252	-0.596617299574976	33	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-1980145	Signaling by NOTCH2	0.550671244925252	-0.596617299574976	33	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.550671244925252	-0.596617299574976	33	1	0.0040650406504065	246	10287	4958	OMD
R-HSA-392518	Signal amplification	0.550671244925252	-0.596617299574976	33	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-389356	CD28 co-stimulation	0.550671244925252	-0.596617299574976	33	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-202433	Generation of second messenger molecules	0.550671244925252	-0.596617299574976	33	1	0.0040650406504065	246	10287	55740	ENAH
R-HSA-948021	Transport to the Golgi and subsequent modification	0.554792176575323	-0.58916169198313	164	4	0.016260162601626	246	10287	57134,288,79090,338596	MAN1C1,ANK3,TRAPPC6A,ST8SIA6
R-HSA-112399	IRS-mediated signalling	0.558890154870044	-0.581802328052108	294	7	0.0284552845528455	246	10287	2549,2252,3815,5295,2905,816,4684	GAB1,FGF7,KIT,PIK3R1,GRIN2C,CAMK2B,NCAM1
R-HSA-1433557	Signaling by SCF-KIT	0.559432288633682	-0.580832779762604	337	8	0.032520325203252	246	10287	2905,816,2252,400581,4684,5295,3815,2549	GRIN2C,CAMK2B,FGF7,GRAPL,NCAM1,PIK3R1,KIT,GAB1
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.56145092832768	-0.577230902518203	34	1	0.0040650406504065	246	10287	2252	FGF7
R-HSA-71387	Metabolism of carbohydrates	0.566135959144268	-0.568921019122637	296	7	0.0284552845528455	246	10287	5224,5260,6382,4958,5105,8908,216	PGAM2,PHKG1,SDC1,OMD,PCK1,GYG2,ALDH1A1
R-HSA-1483255	PI Metabolism	0.567207628689282	-0.567029854120389	79	2	0.00813008130081301	246	10287	5295,375775	PIK3R1,PNPLA7
R-HSA-74751	Insulin receptor signalling cascade	0.569738752117238	-0.562577352837546	297	7	0.0284552845528455	246	10287	4684,2905,816,5295,3815,2252,2549	NCAM1,GRIN2C,CAMK2B,PIK3R1,KIT,FGF7,GAB1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.573327859375686	-0.556297545488875	298	7	0.0284552845528455	246	10287	2549,2252,3815,5295,2905,816,4684	GAB1,FGF7,KIT,PIK3R1,GRIN2C,CAMK2B,NCAM1
R-HSA-2428924	IGF1R signaling cascade	0.573327859375686	-0.556297545488875	298	7	0.0284552845528455	246	10287	4684,2252,3815,5295,816,2905,2549	NCAM1,FGF7,KIT,PIK3R1,CAMK2B,GRIN2C,GAB1
R-HSA-912526	Interleukin receptor SHC signaling	0.574187440369457	-0.554799384802496	255	6	0.024390243902439	246	10287	816,5295,2905,2252,3815,4684	CAMK2B,PIK3R1,GRIN2C,FGF7,KIT,NCAM1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.576903076749475	-0.550081004487761	299	7	0.0284552845528455	246	10287	5295,816,2905,3815,2252,4684,2549	PIK3R1,CAMK2B,GRIN2C,KIT,FGF7,NCAM1,GAB1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.582243669754404	-0.540866242317313	36	1	0.0040650406504065	246	10287	2041	EPHA1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.582387471321395	-0.540619294485249	387	9	0.0365853658536585	246	10287	5295,3815,107,4684,2549,2905,816,2252,5136	PIK3R1,KIT,ADCY1,NCAM1,GAB1,GRIN2C,CAMK2B,FGF7,PDE1A
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.587570415104365	-0.531759184649127	82	2	0.00813008130081301	246	10287	3798,113220	KIF5A,KIF12
R-HSA-73884	Base Excision Repair	0.592268843612691	-0.523794619458778	37	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.592268843612691	-0.523794619458778	37	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-451927	Interleukin-2 signaling	0.600780093024126	-0.509526313195463	262	6	0.024390243902439	246	10287	4684,3815,2252,2905,5295,816	NCAM1,KIT,FGF7,GRIN2C,PIK3R1,CAMK2B
R-HSA-156590	Glutathione conjugation	0.602054391383645	-0.507407486619111	38	1	0.0040650406504065	246	10287	2946	GSTM2
R-HSA-449147	Signaling by Interleukins	0.606599781633304	-0.499886043712382	525	12	0.0487804878048781	246	10287	1271,2162,4684,5295,6097,3815,2625,948,5608,2905,816,2252	CNTFR,F13A1,NCAM1,PIK3R1,RORC,KIT,GATA3,CD36,MAP2K6,GRIN2C,CAMK2B,FGF7
R-HSA-1236974	ER-Phagosome pathway	0.607217507872163	-0.498868219534843	85	2	0.00813008130081301	246	10287	948,929	CD36,CD14
R-HSA-69236	G1 Phase	0.611606017843682	-0.491666965466674	39	1	0.0040650406504065	246	10287	1028	CDKN1C
R-HSA-69231	Cyclin D associated events in G1	0.611606017843682	-0.491666965466674	39	1	0.0040650406504065	246	10287	1028	CDKN1C
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.611606017843682	-0.491666965466674	39	1	0.0040650406504065	246	10287	4137	MAPT
R-HSA-114608	Platelet degranulation	0.615505963099725	-0.485310645184048	132	3	0.0121951219512195	246	10287	948,2162,7057	CD36,F13A1,THBS1
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.624162088481321	-0.471345187162161	179	4	0.016260162601626	246	10287	113220,5050,3798,57134	KIF12,PAFAH1B3,KIF5A,MAN1C1
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.626148877448265	-0.468167112757756	88	2	0.00813008130081301	246	10287	5105,948	PCK1,CD36
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.633628764730753	-0.456292040631812	271	6	0.024390243902439	246	10287	5295,2905,816,3815,2252,4684	PIK3R1,GRIN2C,CAMK2B,KIT,FGF7,NCAM1
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.638912407860367	-0.447987910901334	42	1	0.0040650406504065	246	10287	57604	TRMT9B
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.638912407860367	-0.447987910901334	42	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.640618390666217	-0.445321333717417	137	3	0.0121951219512195	246	10287	948,2162,7057	CD36,F13A1,THBS1
R-HSA-8856828	Clathrin-mediated endocytosis	0.640618390666217	-0.445321333717417	137	3	0.0121951219512195	246	10287	127833,338,90019	SYT2,APOB,SYT8
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.644165095578553	-0.439800226138263	229	5	0.0203252032520325	246	10287	2549,2252,3815,5295,974	GAB1,FGF7,KIT,PIK3R1,CD79B
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.644367996836525	-0.439485292418915	91	2	0.00813008130081301	246	10287	929,5608	CD14,MAP2K6
R-HSA-388396	GPCR downstream signaling	0.644509034887391	-0.439266438256791	974	22	0.0894308943089431	246	10287	27115,2147,84033,4987,8622,57449,6755,7432,5745,27334,5295,139189,56656,10268,2149,2911,5136,2788,886,2359,5330,107	PDE7B,F2,OBSCN,OPRL1,PDE8B,PLEKHG5,SSTR5,VIP,PTH1R,P2RY10,PIK3R1,DGKK,OR2S2,RAMP3,F2R,GRM1,PDE1A,GNG7,CCKAR,FPR3,PLCB2,ADCY1
R-HSA-375280	Amine ligand-binding receptors	0.647582739502107	-0.434508710557161	43	1	0.0040650406504065	246	10287	4935	GPR143
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.647582739502107	-0.434508710557161	43	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.647582739502107	-0.434508710557161	43	1	0.0040650406504065	246	10287	55553	SOX6
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.650283802056318	-0.430346392834416	92	2	0.00813008130081301	246	10287	146760,4978	RTN4RL1,OPCML
R-HSA-375165	NCAM signaling for neurite out-growth	0.651183733049058	-0.428963444567332	276	6	0.024390243902439	246	10287	2905,775,816,2252,3815,4684	GRIN2C,CACNA1C,CAMK2B,FGF7,KIT,NCAM1
R-HSA-74752	Signaling by Insulin receptor	0.654895282098237	-0.42327993078738	322	7	0.0284552845528455	246	10287	2549,5295,2905,816,3815,2252,4684	GAB1,PIK3R1,GRIN2C,CAMK2B,KIT,FGF7,NCAM1
R-HSA-917937	Iron uptake and transport	0.656045707688377	-0.4215248161111	44	1	0.0040650406504065	246	10287	30061	SLC40A1
R-HSA-5668914	Diseases of metabolism	0.656045707688377	-0.4215248161111	44	1	0.0040650406504065	246	10287	8908	GYG2
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.656121475500292	-0.421409331113501	93	2	0.00813008130081301	246	10287	929,5608	CD14,MAP2K6
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.656121475500292	-0.421409331113501	93	2	0.00813008130081301	246	10287	5608,929	MAP2K6,CD14
R-HSA-6811438	Intra-Golgi traffic	0.66430625204396	-0.409012012878547	45	1	0.0040650406504065	246	10287	57134	MAN1C1
R-HSA-166658	Complement cascade	0.66430625204396	-0.409012012878547	45	1	0.0040650406504065	246	10287	730	C7
R-HSA-446652	Interleukin-1 signaling	0.672369195020789	-0.396947691970094	46	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-4086400	PCP/CE pathway	0.673169220705175	-0.395758538588354	96	2	0.00813008130081301	246	10287	8325,144165	FZD8,PRICKLE1
R-HSA-446203	Asparagine N-linked glycosylation	0.678190248160074	-0.388327428397113	284	6	0.024390243902439	246	10287	256435,288,57134,129807,79090,338596	ST6GALNAC3,ANK3,MAN1C1,NEU4,TRAPPC6A,ST8SIA6
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.678698018917253	-0.387578994213987	97	2	0.00813008130081301	246	10287	5608,929	MAP2K6,CD14
R-HSA-8948216	Collagen chain trimerization	0.680239244628285	-0.38531071235405	47	1	0.0040650406504065	246	10287	81578	COL21A1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.687920997146539	-0.374081277371099	48	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-380108	Chemokine receptors bind chemokines	0.687920997146539	-0.374081277371099	48	1	0.0040650406504065	246	10287	51554	ACKR4
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.687920997146539	-0.374081277371099	48	1	0.0040650406504065	246	10287	1628	DBP
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.68952755627424	-0.371748616957478	99	2	0.00813008130081301	246	10287	5608,929	MAP2K6,CD14
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.68952755627424	-0.371748616957478	99	2	0.00813008130081301	246	10287	5608,929	MAP2K6,CD14
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.68952755627424	-0.371748616957478	99	2	0.00813008130081301	246	10287	929,5608	CD14,MAP2K6
R-HSA-418594	G alpha (i) signalling events	0.691576563969517	-0.368781412430921	242	5	0.0203252032520325	246	10287	107,2359,6755,2788,4987	ADCY1,FPR3,SSTR5,GNG7,OPRL1
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.697869362822086	-0.359723353016927	197	4	0.016260162601626	246	10287	2549,5295,3815,2252	GAB1,PIK3R1,KIT,FGF7
R-HSA-5610787	Hedgehog 'off' state	0.700056220546724	-0.356594632097066	101	2	0.00813008130081301	246	10287	107,2735	ADCY1,GLI1
R-HSA-112412	SOS-mediated signalling	0.701887685161865	-0.35398188040343	245	5	0.0203252032520325	246	10287	4684,2905,816,3815,2252	NCAM1,GRIN2C,CAMK2B,KIT,FGF7
R-HSA-5673001	RAF/MAP kinase cascade	0.701887685161865	-0.35398188040343	245	5	0.0203252032520325	246	10287	2252,3815,2905,816,4684	FGF7,KIT,GRIN2C,CAMK2B,NCAM1
R-HSA-180336	SHC1 events in EGFR signaling	0.701887685161865	-0.35398188040343	245	5	0.0203252032520325	246	10287	2252,3815,2905,816,4684	FGF7,KIT,GRIN2C,CAMK2B,NCAM1
R-HSA-179812	GRB2 events in EGFR signaling	0.701887685161865	-0.35398188040343	245	5	0.0203252032520325	246	10287	4684,2252,3815,2905,816	NCAM1,FGF7,KIT,GRIN2C,CAMK2B
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.702737453250232	-0.352771923143233	50	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.709880814251193	-0.342658190289901	51	1	0.0040650406504065	246	10287	2209	FCGR1A
R-HSA-112310	Neurotransmitter Release Cycle	0.709880814251193	-0.342658190289901	51	1	0.0040650406504065	246	10287	9256	TSPOAP1
R-HSA-383280	Nuclear Receptor transcription pathway	0.709880814251193	-0.342658190289901	51	1	0.0040650406504065	246	10287	6097	RORC
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.709880814251193	-0.342658190289901	51	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-195258	RHO GTPase Effectors	0.71001488384379	-0.342469346006232	294	6	0.024390243902439	246	10287	401541,54763,10398,10811,4638,3798	CENPP,ROPN1,MYL9,NOXA1,MYLK,KIF5A
R-HSA-913531	Interferon Signaling	0.712768489274589	-0.33859861076876	201	4	0.016260162601626	246	10287	2317,2209,816,4684	FLNB,FCGR1A,CAMK2B,NCAM1
R-HSA-170984	ARMS-mediated activation	0.715263361652326	-0.335104466132627	249	5	0.0203252032520325	246	10287	2905,816,2252,3815,4684	GRIN2C,CAMK2B,FGF7,KIT,NCAM1
R-HSA-187706	Signalling to p38 via RIT and RIN	0.715263361652326	-0.335104466132627	249	5	0.0203252032520325	246	10287	4684,3815,2252,2905,816	NCAM1,KIT,FGF7,GRIN2C,CAMK2B
R-HSA-170968	Frs2-mediated activation	0.718540621718289	-0.330533038222946	250	5	0.0203252032520325	246	10287	2252,3815,816,2905,4684	FGF7,KIT,CAMK2B,GRIN2C,NCAM1
R-HSA-5684996	MAPK1/MAPK3 signaling	0.721791200227842	-0.326019378274971	251	5	0.0203252032520325	246	10287	3815,2252,816,2905,4684	KIT,FGF7,CAMK2B,GRIN2C,NCAM1
R-HSA-75153	Apoptotic execution  phase	0.723658680461442	-0.323435433583966	53	1	0.0040650406504065	246	10287	4137	MAPT
R-HSA-169893	Prolonged ERK activation events	0.725015097653683	-0.321562799994378	252	5	0.0203252032520325	246	10287	3815,2252,816,2905,4684	KIT,FGF7,CAMK2B,GRIN2C,NCAM1
R-HSA-2586552	Signaling by Leptin	0.728212319682595	-0.317162625390784	253	5	0.0203252032520325	246	10287	4684,816,2905,2252,3815	NCAM1,CAMK2B,GRIN2C,FGF7,KIT
R-HSA-382556	ABC-family proteins mediated transport	0.729879594486667	-0.314875697503003	107	2	0.00813008130081301	246	10287	225,5244	ABCD2,ABCB4
R-HSA-114604	GPVI-mediated activation cascade	0.730301241008189	-0.314298171044646	54	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.730301241008189	-0.314298171044646	54	1	0.0040650406504065	246	10287	6382	SDC1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.733328923570428	-0.310160941634972	158	3	0.0121951219512195	246	10287	23539,7351,5166	SLC16A8,UCP2,PDK4
R-HSA-167044	Signalling to RAS	0.737644066651794	-0.304293865232834	256	5	0.0203252032520325	246	10287	3815,2252,816,2905,4684	KIT,FGF7,CAMK2B,GRIN2C,NCAM1
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.74379885103453	-0.295984642216036	258	5	0.0203252032520325	246	10287	4684,2905,816,3815,2252	NCAM1,GRIN2C,CAMK2B,KIT,FGF7
R-HSA-1280218	Adaptive Immune System	0.748745440294375	-0.289356219328116	810	17	0.0691056910569106	246	10287	55740,4068,5133,974,2209,2252,929,3798,948,2549,4008,54209,2214,3815,140458,5295,92591	ENAH,SH2D1A,PDCD1,CD79B,FCGR1A,FGF7,CD14,KIF5A,CD36,GAB1,LMO7,TREM2,FCGR3A,KIT,ASB5,PIK3R1,ASB16
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.755318588457677	-0.280615647270912	58	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.755318588457677	-0.280615647270912	58	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.755318588457677	-0.280615647270912	58	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.755318588457677	-0.280615647270912	58	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.755318588457677	-0.280615647270912	58	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-187687	Signalling to ERKs	0.758722174029201	-0.276119610718543	263	5	0.0203252032520325	246	10287	4684,3815,2252,2905,816	NCAM1,KIT,FGF7,GRIN2C,CAMK2B
R-HSA-2142753	Arachidonic acid metabolism	0.761202998186202	-0.272855204805154	59	1	0.0040650406504065	246	10287	5740	PTGIS
R-HSA-2871796	FCERI mediated MAPK activation	0.764507054671299	-0.268524025831791	265	5	0.0203252032520325	246	10287	4684,2252,3815,2905,816	NCAM1,FGF7,KIT,GRIN2C,CAMK2B
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.766946453641357	-0.265338292775035	60	1	0.0040650406504065	246	10287	3549	IHH
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.772552317777694	-0.258055547224921	61	1	0.0040650406504065	246	10287	2735	GLI1
R-HSA-202403	TCR signaling	0.782033380496323	-0.245857853291171	119	2	0.00813008130081301	246	10287	55740,5295	ENAH,PIK3R1
R-HSA-450294	MAP kinase activation in TLR cascade	0.7885768041967	-0.237525471873439	64	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-8873719	RAB geranylgeranylation	0.7885768041967	-0.237525471873439	64	1	0.0040650406504065	246	10287	25837	RAB26
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.791868673049207	-0.233359717773907	372	7	0.0284552845528455	246	10287	2252,3815,5295,816,2905,4684,2549	FGF7,KIT,PIK3R1,CAMK2B,GRIN2C,NCAM1,GAB1
R-HSA-168249	Innate Immune System	0.793377295721124	-0.231456387745542	1285	27	0.109756097560976	246	10287	79895,143662,5136,6039,338,11001,816,2905,5608,122618,4353,4684,5023,9450,107,2209,948,2252,730,929,2214,54209,10396,2549,4589,5295,3815	ATP8B4,MUC15,PDE1A,RNASE6,APOB,SLC27A2,CAMK2B,GRIN2C,MAP2K6,PLD4,MPO,NCAM1,P2RX1,LY86,ADCY1,FCGR1A,CD36,FGF7,C7,CD14,FCGR3A,TREM2,ATP8A1,GAB1,MUC7,PIK3R1,KIT
R-HSA-1630316	Glycosaminoglycan metabolism	0.801032713198104	-0.221853492300656	124	2	0.00813008130081301	246	10287	6382,4958	SDC1,OMD
R-HSA-5358346	Hedgehog ligand biogenesis	0.803476574930496	-0.218807248018602	67	1	0.0040650406504065	246	10287	3549	IHH
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.806415208488207	-0.215156522110476	330	6	0.024390243902439	246	10287	4684,2905,816,5295,3815,2252	NCAM1,GRIN2C,CAMK2B,PIK3R1,KIT,FGF7
R-HSA-216083	Integrin cell surface interactions	0.808206982248886	-0.212937087116376	68	1	0.0040650406504065	246	10287	7057	THBS1
R-HSA-1280215	Cytokine Signaling in Immune system	0.810170917157235	-0.210510044738793	756	15	0.0609756097560976	246	10287	2209,948,2625,2252,2905,5608,816,2317,2162,1271,1154,4684,3815,6097,5295	FCGR1A,CD36,GATA3,FGF7,GRIN2C,MAP2K6,CAMK2B,FLNB,F13A1,CNTFR,CISH,NCAM1,KIT,RORC,PIK3R1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.812823978251295	-0.207240701791762	69	1	0.0040650406504065	246	10287	79090	TRAPPC6A
R-HSA-597592	Post-translational protein modification	0.816709964432696	-0.202471247844173	1034	21	0.0853658536585366	246	10287	79090,157869,256435,288,57134,143662,493861,415,25837,9719,146760,5624,4978,10417,4589,129807,7057,338596,2625,374907,2147	TRAPPC6A,SBSPON,ST6GALNAC3,ANK3,MAN1C1,MUC15,EID3,ARSE,RAB26,ADAMTSL2,RTN4RL1,PROC,OPCML,SPON2,MUC7,NEU4,THBS1,ST8SIA6,GATA3,B3GNT8,F2
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.817330271199071	-0.201712017094958	70	1	0.0040650406504065	246	10287	81578	COL21A1
R-HSA-400253	Circadian Clock	0.821728504861719	-0.196345224538712	71	1	0.0040650406504065	246	10287	1628	DBP
R-HSA-194138	Signaling by VEGF	0.824067023047958	-0.193503413730039	338	6	0.024390243902439	246	10287	4684,5295,2905,816,3815,2252	NCAM1,PIK3R1,GRIN2C,CAMK2B,KIT,FGF7
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.82602126012283	-0.191134767144898	72	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-774815	Nucleosome assembly	0.82602126012283	-0.191134767144898	72	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-5683057	MAPK family signaling cascades	0.828210464145199	-0.188487973145853	290	5	0.0203252032520325	246	10287	4684,816,2905,3815,2252	NCAM1,CAMK2B,GRIN2C,KIT,FGF7
R-HSA-1980143	Signaling by NOTCH1	0.830211056503266	-0.186075325572736	73	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-199977	ER to Golgi Anterograde Transport	0.831565818316812	-0.184444827358189	133	2	0.00813008130081301	246	10287	288,79090	ANK3,TRAPPC6A
R-HSA-174824	Lipoprotein metabolism	0.834300353566468	-0.181161805286031	74	1	0.0040650406504065	246	10287	338	APOB
R-HSA-1169408	ISG15 antiviral mechanism	0.84218699673411	-0.171753203014787	76	1	0.0040650406504065	246	10287	2317	FLNB
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.84218699673411	-0.171753203014787	76	1	0.0040650406504065	246	10287	2317	FLNB
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.845988974861948	-0.167248951538908	77	1	0.0040650406504065	246	10287	10370	CITED2
R-HSA-2262749	Cellular response to hypoxia	0.845988974861948	-0.167248951538908	77	1	0.0040650406504065	246	10287	10370	CITED2
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.849699720414127	-0.162872262013384	78	1	0.0040650406504065	246	10287	493861	EID3
R-HSA-6807878	COPI-mediated anterograde transport	0.853321413923387	-0.158618998332724	79	1	0.0040650406504065	246	10287	288	ANK3
R-HSA-5621481	C-type lectin receptors (CLRs)	0.863127661414177	-0.147192671360132	144	2	0.00813008130081301	246	10287	143662,4589	MUC15,MUC7
R-HSA-71291	Metabolism of amino acids and derivatives	0.867790574787379	-0.141804866719299	361	6	0.024390243902439	246	10287	2593,2875,374569,4948,5053,57571	GAMT,GPT,ASPG,OCA2,PAH,CARNS1
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.870166852402149	-0.139070301351492	84	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.870166852402149	-0.139070301351492	84	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.870166852402149	-0.139070301351492	84	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-351202	Metabolism of polyamines	0.879334173476363	-0.128590278941643	87	1	0.0040650406504065	246	10287	2593	GAMT
R-HSA-3371556	Cellular response to heat stress	0.885084616976272	-0.122072026142215	89	1	0.0040650406504065	246	10287	816	CAMK2B
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.885084616976272	-0.122072026142215	89	1	0.0040650406504065	246	10287	79090	TRAPPC6A
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.886788110681089	-0.120149208320057	373	6	0.024390243902439	246	10287	948,92591,929,140458,4008,2209	CD36,ASB16,CD14,ASB5,LMO7,FCGR1A
R-HSA-6805567	Keratinization	0.890367914376036	-0.116120514737426	214	3	0.0121951219512195	246	10287	11005,6768,3851	SPINK5,ST14,KRT4
R-HSA-2980736	Peptide hormone metabolism	0.890562078642418	-0.115902466562694	91	1	0.0040650406504065	246	10287	3798	KIF5A
R-HSA-1474290	Collagen formation	0.895779466906872	-0.11006102698663	93	1	0.0040650406504065	246	10287	81578	COL21A1
R-HSA-5625740	RHO GTPases activate PKNs	0.895779466906872	-0.11006102698663	93	1	0.0040650406504065	246	10287	10398	MYL9
R-HSA-6803157	Antimicrobial peptides	0.905482645553648	-0.0992871674374195	97	1	0.0040650406504065	246	10287	6039	RNASE6
R-HSA-15869	Metabolism of nucleotides	0.905482645553648	-0.0992871674374195	97	1	0.0040650406504065	246	10287	26289	AK5
R-HSA-202424	Downstream TCR signaling	0.907764418788423	-0.0967703847175358	98	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-390466	Chaperonin-mediated protein folding	0.909991325543366	-0.0943202118866018	99	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-977225	Amyloid fiber formation	0.91428576447895	-0.0896121037908373	101	1	0.0040650406504065	246	10287	6622	SNCA
R-HSA-2132295	MHC class II antigen presentation	0.918376102947165	-0.0851482740655118	103	1	0.0040650406504065	246	10287	3798	KIF5A
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.918376102947165	-0.0851482740655118	103	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.920347772096064	-0.0830036672201251	104	1	0.0040650406504065	246	10287	493861	EID3
R-HSA-109581	Apoptosis	0.920604724025231	-0.0827245161487345	172	2	0.00813008130081301	246	10287	929,4137	CD14,MAPT
R-HSA-391251	Protein folding	0.922272003473826	-0.0809150843201036	105	1	0.0040650406504065	246	10287	2788	GNG7
R-HSA-156580	Phase II conjugation	0.924149933859326	-0.0788809544226474	106	1	0.0040650406504065	246	10287	2946	GSTM2
R-HSA-5357801	Programmed Cell Death	0.925196872509492	-0.0777487289705018	175	2	0.00813008130081301	246	10287	929,4137	CD14,MAPT
R-HSA-72306	tRNA processing	0.929516883853744	-0.0730903075383327	109	1	0.0040650406504065	246	10287	57604	TRMT9B
R-HSA-73886	Chromosome Maintenance	0.929516883853744	-0.0730903075383327	109	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-2990846	SUMOylation	0.931220445111442	-0.0712592465850731	110	1	0.0040650406504065	246	10287	493861	EID3
R-HSA-68877	Mitotic Prometaphase	0.932882995042887	-0.0694754932412889	111	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-157118	Signaling by NOTCH	0.934505516969079	-0.0677377484452208	112	1	0.0040650406504065	246	10287	3714	JAG2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.936088970810279	-0.0660447527374314	113	1	0.0040650406504065	246	10287	7351	UCP2
R-HSA-5663220	RHO GTPases Activate Formins	0.942050511861199	-0.059696383910046	117	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-168256	Immune System	0.943394021114387	-0.0582712457454583	2101	41	0.166666666666667	246	10287	2209,3798,929,730,2625,2549,2214,4008,5295,4589,140458,3815,92591,6039,55740,1271,122618,6097,9450,5133,4068,4684,2252,948,2162,10396,54209,1154,5136,143662,79895,11001,5608,2905,816,338,2317,4353,5023,107,974	FCGR1A,KIF5A,CD14,C7,GATA3,GAB1,FCGR3A,LMO7,PIK3R1,MUC7,ASB5,KIT,ASB16,RNASE6,ENAH,CNTFR,PLD4,RORC,LY86,PDCD1,SH2D1A,NCAM1,FGF7,CD36,F13A1,ATP8A1,TREM2,CISH,PDE1A,MUC15,ATP8B4,SLC27A2,MAP2K6,GRIN2C,CAMK2B,APOB,FLNB,MPO,P2RX1,ADCY1,CD79B
R-HSA-6798695	Neutrophil degranulation	0.950339598022914	-0.0509358866622345	487	7	0.0284552845528455	246	10287	10396,4353,79895,929,11001,5023,948	ATP8A1,MPO,ATP8B4,CD14,SLC27A2,P2RX1,CD36
R-HSA-5653656	Vesicle-mediated transport	0.953235221195647	-0.0478935839621838	650	10	0.040650406504065	246	10287	90019,3798,113220,338,948,57134,5050,288,127833,79090	SYT8,KIF5A,KIF12,APOB,CD36,MAN1C1,PAFAH1B3,ANK3,SYT2,TRAPPC6A
R-HSA-2559580	Oxidative Stress Induced Senescence	0.95351597788492	-0.0475990969924757	126	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-199991	Membrane Trafficking	0.96003345540802	-0.0407871457441265	610	9	0.0365853658536585	246	10287	90019,3798,113220,338,79090,127833,57134,5050,288	SYT8,KIF5A,KIF12,APOB,TRAPPC6A,SYT2,MAN1C1,PAFAH1B3,ANK3
R-HSA-1500931	Cell-Cell communication	0.960846076282905	-0.0399410532016678	133	1	0.0040650406504065	246	10287	5295	PIK3R1
R-HSA-2262752	Cellular responses to stress	0.962213365621488	-0.0385190591237057	451	6	0.024390243902439	246	10287	10370,6648,2878,5608,816,50507	CITED2,SOD2,GPX3,MAP2K6,CAMK2B,NOX4
R-HSA-453279	Mitotic G1-G1/S phases	0.969365142715702	-0.0311139138037939	143	1	0.0040650406504065	246	10287	1028	CDKN1C
R-HSA-5633007	Regulation of TP53 Activity	0.980792994800264	-0.0193938561582171	162	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.981077313204209	-0.0191040119164486	311	3	0.0121951219512195	246	10287	4008,140458,92591	LMO7,ASB5,ASB16
R-HSA-2467813	Separation of Sister Chromatids	0.983428899630759	-0.0167099369734623	168	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-68882	Mitotic Anaphase	0.987360804190354	-0.0127197499242617	179	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.987668406297445	-0.0124082587240862	180	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-2559583	Cellular Senescence	0.991688689091403	-0.0083460424299703	196	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-5689880	Ub-specific processing proteases	0.995735262762487	-0.00427385716800605	223	1	0.0040650406504065	246	10287	2625	GATA3
R-HSA-5663205	Infectious disease	0.995871683297971	-0.00413686172724766	388	3	0.0121951219512195	246	10287	127833,9899,5608	SYT2,SV2B,MAP2K6
R-HSA-392499	Metabolism of proteins	0.997795306304607	-0.00220712761055452	1619	24	0.0975609756097561	246	10287	146760,5624,10417,4978,6622,4589,7057,129807,338596,2625,2147,3798,374907,79090,157869,256435,288,57134,143662,493861,2788,415,25837,9719	RTN4RL1,PROC,SPON2,OPCML,SNCA,MUC7,THBS1,NEU4,ST8SIA6,GATA3,F2,KIF5A,B3GNT8,TRAPPC6A,SBSPON,ST6GALNAC3,ANK3,MAN1C1,MUC15,EID3,GNG7,ARSE,RAB26,ADAMTSL2
R-HSA-5688426	Deubiquitination	0.999385792017549	-0.000614396685446206	301	1	0.0040650406504065	246	10287	2625	GATA3
R-HSA-68886	M Phase	0.999484220416999	-0.000515912643045026	308	1	0.0040650406504065	246	10287	401541	CENPP
R-HSA-73894	DNA Repair	0.999577612623562	-0.000422476607113285	316	1	0.0040650406504065	246	10287	4913	NTHL1
R-HSA-3700989	Transcriptional Regulation by TP53	0.999882240242641	-0.000117766691583523	367	1	0.0040650406504065	246	10287	5608	MAP2K6
R-HSA-381753	Olfactory Signaling Pathway	0.999935589765139	-6.44123092888776e-05	391	1	0.0040650406504065	246	10287	56656	OR2S2
R-HSA-69278	Cell Cycle, Mitotic	0.999959237969505	-4.07628612894456e-05	514	2	0.00813008130081301	246	10287	1028,401541	CDKN1C,CENPP
R-HSA-212436	Generic Transcription Pathway	0.999995599230967	-4.40077871606525e-06	865	5	0.0203252032520325	246	10287	10370,3815,1490,5608,6097	CITED2,KIT,CCN2,MAP2K6,RORC
R-HSA-1640170	Cell Cycle	0.99999683412203	-3.1658829811042e-06	621	2	0.00813008130081301	246	10287	401541,1028	CENPP,CDKN1C
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-164944	Nef and signal transduction	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-5576890	Phase 3 - rapid repolarisation	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-804914	Transport of fatty acids	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-73942	DNA Damage Reversal	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-68952	DNA replication initiation	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-977347	Serine biosynthesis	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-444821	Relaxin receptors	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-1483115	Hydrolysis of LPC	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-448424	Interleukin-17 signaling	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-72731	Recycling of eIF2:GDP	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-196783	Coenzyme A biosynthesis	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999971629	-2.83713920283218e-11	8	0	0	246	10287
R-HSA-74160	Gene Expression	0.999999999976485	-2.35154456427762e-11	1821	6	0.024390243902439	246	10287	10370,6097,5608,57604,3815,1490	CITED2,RORC,MAP2K6,TRMT9B,KIT,CCN2
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-174403	Glutathione synthesis and recycling	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-69166	Removal of the Flap Intermediate	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-177504	Retrograde neurotrophin signalling	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-209952	Peptide hormone biosynthesis	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-428540	Activation of Rac	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-877312	Regulation of IFNG signaling	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-69091	Polymerase switching	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-2024101	CS/DS degradation	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-209560	NF-kB is activated and signals survival	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-190322	FGFR4 ligand binding and activation	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-69109	Leading Strand Synthesis	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-5675482	Regulation of necroptotic cell death	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999982729	-1.72706723160771e-11	14	0	0	246	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-190861	Gap junction assembly	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-156584	Cytosolic sulfonation of small molecules	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-8876725	Protein methylation	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999985555	-1.44450715699548e-11	19	0	0	246	10287
R-HSA-392517	Rap1 signalling	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-110312	Translesion synthesis by REV1	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-190242	FGFR1 ligand binding and activation	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-5218859	Regulated Necrosis	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-159418	Recycling of bile acids and salts	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-1170546	Prolactin receptor signaling	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999986039	-1.39606324135662e-11	16	0	0	246	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999986317	-1.36830073630263e-11	82	0	0	246	10287
R-HSA-380287	Centrosome maturation	0.999999999986317	-1.36830073630263e-11	82	0	0	246	10287
R-HSA-75109	Triglyceride Biosynthesis	0.999999999986317	-1.36830073630263e-11	82	0	0	246	10287
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.999999999986317	-1.36830073630263e-11	82	0	0	246	10287
R-HSA-157579	Telomere Maintenance	0.999999999986317	-1.36830073630263e-11	82	0	0	246	10287
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-75205	Dissolution of Fibrin Clot	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-211227	Activation of DNA fragmentation factor	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-1502540	Signaling by Activin	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-2408517	SeMet incorporation into proteins	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-350054	Notch-HLH transcription pathway	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-2168880	Scavenging of heme from plasma	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-190239	FGFR3 ligand binding and activation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-190372	FGFR3c ligand binding and activation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-140342	Apoptosis induced DNA fragmentation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-74217	Purine salvage	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-171007	p38MAPK events	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-375281	Hormone ligand-binding receptors	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-71240	Tryptophan catabolism	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-175474	Assembly Of The HIV Virion	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-75892	Platelet Adhesion to exposed collagen	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-190375	FGFR2c ligand binding and activation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-202670	ERKs are inactivated	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-977441	GABA A receptor activation	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.999999999987419	-1.25811842514673e-11	13	0	0	246	10287
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-72086	mRNA Capping	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.999999999988649	-1.13507648927061e-11	29	0	0	246	10287
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-113510	E2F mediated regulation of DNA replication	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-1483166	Synthesis of PA	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-5656169	Termination of translesion DNA synthesis	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-73847	Purine metabolism	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-5694530	Cargo concentration in the ER	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999988946	-1.10538524857362e-11	34	0	0	246	10287
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.99999999999044	-9.55989472354824e-12	60	0	0	246	10287
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.99999999999044	-9.55989472354824e-12	60	0	0	246	10287
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.99999999999044	-9.55989472354824e-12	60	0	0	246	10287
R-HSA-6784531	tRNA processing in the nucleus	0.99999999999044	-9.55989472354824e-12	60	0	0	246	10287
R-HSA-1482801	Acyl chain remodelling of PS	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-166663	Initial triggering of complement	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-198753	ERK/MAPK targets	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999990889	-9.11067007567105e-12	22	0	0	246	10287
R-HSA-437239	Recycling pathway of L1	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-190828	Gap junction trafficking	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-1368082	RORA activates gene expression	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999992646	-7.35373709395031e-12	28	0	0	246	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-70635	Urea cycle	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-74749	Signal attenuation	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-727802	Transport of nucleotide sugars	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-74259	Purine catabolism	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-201688	WNT mediated activation of DVL	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-3215018	Processing and activation of SUMO	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-110056	MAPK3 (ERK1) activation	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-418886	Netrin mediated repulsion signals	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-190873	Gap junction degradation	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-193692	Regulated proteolysis of p75NTR	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-1300644	Interaction With The Zona Pellucida	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-428643	Organic anion transporters	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-209968	Thyroxine biosynthesis	0.99999999999277	-7.23019727711198e-12	10	0	0	246	10287
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-8875791	MET activates STAT3	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-844615	The AIM2 inflammasome	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-198745	Signalling to STAT3	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-191650	Regulation of gap junction activity	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-844455	The NLRP1 inflammasome	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-111458	Formation of apoptosome	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-8849472	PTK6 Down-Regulation	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-73927	Depurination	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-977442	GABA A (rho) receptor activation	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-110331	Cleavage of the damaged purine	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-193681	Ceramide signalling	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1296067	Potassium transport channels	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-163282	Mitochondrial transcription initiation	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-77108	Utilization of Ketone Bodies	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5653890	Lactose synthesis	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-6806664	Metabolism of vitamin K	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-351200	Interconversion of polyamines	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999992848	-7.15173555854078e-12	3	0	0	246	10287
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-390696	Adrenoceptors	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-75094	Formation of the Editosome	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-162592	Integration of provirus	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-196025	Formation of annular gap junctions	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-1462054	Alpha-defensins	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-391908	Prostanoid ligand receptors	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-419771	Opsins	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-1300642	Sperm Motility And Taxes	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-159424	Conjugation of carboxylic acids	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-2214320	Anchoring fibril formation	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-447041	CHL1 interactions	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-156587	Amino Acid conjugation	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-425986	Sodium/Proton exchangers	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999993238	-6.76190548427693e-12	9	0	0	246	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-3371568	Attenuation phase	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-69183	Processive synthesis on the lagging strand	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5682910	LGI-ADAM interactions	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-156581	Methylation	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-5358508	Mismatch Repair	0.999999999993577	-6.42334621318334e-12	15	0	0	246	10287
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.999999999994163	-5.83685581506478e-12	46	0	0	246	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	0.999999999994163	-5.83685581506478e-12	46	0	0	246	10287
R-HSA-70153	Glucose transport	0.999999999994163	-5.83685581506478e-12	46	0	0	246	10287
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-196780	Biotin transport and metabolism	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-8851805	MET activates RAS signaling	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-189451	Heme biosynthesis	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-5661231	Metallothioneins bind metals	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-1059683	Interleukin-6 signaling	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-75072	mRNA Editing	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-5660526	Response to metal ions	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-549127	Organic cation transport	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-193048	Androgen biosynthesis	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-446107	Type I hemidesmosome assembly	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-3371378	Regulation by c-FLIP	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-69416	Dimerization of procaspase-8	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-211999	CYP2E1 reactions	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-376172	DSCAM interactions	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-73614	Pyrimidine salvage reactions	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-5218900	CASP8 activity is inhibited	0.999999999994271	-5.72881570293174e-12	11	0	0	246	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.999999999994682	-5.31818365619116e-12	48	0	0	246	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	0.999999999994682	-5.31818365619116e-12	48	0	0	246	10287
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.999999999994682	-5.31818365619116e-12	48	0	0	246	10287
R-HSA-69002	DNA Replication Pre-Initiation	0.999999999994969	-5.0309624173798e-12	86	0	0	246	10287
R-HSA-68874	M/G1 Transition	0.999999999994969	-5.0309624173798e-12	86	0	0	246	10287
R-HSA-167161	HIV Transcription Initiation	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.999999999995051	-4.9487663090422e-12	47	0	0	246	10287
R-HSA-73887	Death Receptor Signalling	0.999999999995344	-4.65561014425112e-12	50	0	0	246	10287
R-HSA-73893	DNA Damage Bypass	0.999999999995344	-4.65561014425112e-12	50	0	0	246	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999995344	-4.65561014425112e-12	50	0	0	246	10287
R-HSA-6802949	Signaling by RAS mutants	0.999999999995344	-4.65561014425112e-12	50	0	0	246	10287
R-HSA-167169	HIV Transcription Elongation	0.999999999995344	-4.65561014425112e-12	50	0	0	246	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999995344	-4.65561014425112e-12	50	0	0	246	10287
R-HSA-933542	TRAF6 mediated NF-kB activation	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-429947	Deadenylation of mRNA	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-1538133	G0 and Early G1	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-211981	Xenobiotics	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-5673000	RAF activation	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-162588	Budding and maturation of HIV virion	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-3000157	Laminin interactions	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-182971	EGFR downregulation	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999995935	-4.06508658694251e-12	25	0	0	246	10287
R-HSA-428808	Na+-dependent glucose transporters	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5676934	Protein repair	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-444257	RSK activation	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-205025	NADE modulates death signalling	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-388479	Vasopressin-like receptors	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-211916	Vitamins	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-189483	Heme degradation	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-187015	Activation of TRKA receptors	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-6799990	Metal sequestration by antimicrobial proteins	0.999999999997166	-2.83420694426685e-12	6	0	0	246	10287
R-HSA-5683826	Surfactant metabolism	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-381042	PERK regulates gene expression	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-917977	Transferrin endocytosis and recycling	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-157858	Gap junction trafficking and regulation	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-420029	Tight junction interactions	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-5669034	TNFs bind their physiological receptors	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-8863795	Downregulation of ERBB2 signaling	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.999999999997379	-2.62142719645419e-12	30	0	0	246	10287
R-HSA-428776	Class II GLUTs	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-167060	NGF processing	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-442745	Activation of CaMK IV	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-390650	Histamine receptors	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-173736	Alternative complement activation	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-165158	Activation of AKT2	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-417973	Adenosine P1 receptors	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-173107	Binding and entry of HIV virion	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-1296061	HCN channels	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-209905	Catecholamine biosynthesis	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-8848584	Wax biosynthesis	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-209563	Axonal growth stimulation	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-6783984	Glycine degradation	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-140179	Amine Oxidase reactions	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-8849474	PTK6 Activates STAT3	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-1296053	Classical Kir channels	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-8935690	Miscellaneous digestion events	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-447115	Interleukin-12 signaling	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-888593	Reuptake of GABA	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.999999999997571	-2.42846413103482e-12	4	0	0	246	10287
R-HSA-4641258	Degradation of DVL	0.999999999998882	-1.11787296160437e-12	59	0	0	246	10287
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.999999999999101	-8.99443115278219e-13	81	0	0	246	10287
R-HSA-191273	Cholesterol biosynthesis	0.999999999999131	-8.69218860537704e-13	24	0	0	246	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999999131	-8.69218860537704e-13	24	0	0	246	10287
R-HSA-156588	Glucuronidation	0.999999999999131	-8.69218860537704e-13	24	0	0	246	10287
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999999131	-8.69218860537704e-13	24	0	0	246	10287
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.999999999999131	-8.69218860537704e-13	24	0	0	246	10287
R-HSA-156842	Eukaryotic Translation Elongation	1.00000000000017	1.70095440910941e-13	96	0	0	246	10287
R-HSA-72764	Eukaryotic Translation Termination	1.00000000000017	1.70095440910941e-13	96	0	0	246	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-912694	Regulation of IFNA signaling	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-1187000	Fertilization	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-1474165	Reproduction	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-73848	Pyrimidine metabolism	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1.00000000000053	5.32792066211379e-13	26	0	0	246	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-6804757	Regulation of TP53 Degradation	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-933541	TRAF6 mediated IRF7 activation	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-113418	Formation of the Early Elongation Complex	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-5693537	Resolution of D-Loop Structures	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	1.00000000000089	8.85801783965296e-13	35	0	0	246	10287
R-HSA-909733	Interferon alpha/beta signaling	1.00000000000118	1.18075727104074e-12	69	0	0	246	10287
R-HSA-5619084	ABC transporter disorders	1.00000000000118	1.18075727104074e-12	69	0	0	246	10287
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	1.00000000000118	1.18075727104074e-12	69	0	0	246	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	1.00000000000118	1.18075727104074e-12	69	0	0	246	10287
R-HSA-68867	Assembly of the pre-replicative complex	1.00000000000118	1.18075727104074e-12	69	0	0	246	10287
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000000118	1.18075727104074e-12	69	0	0	246	10287
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-2028269	Signaling by Hippo	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-6807004	Negative regulation of MET activity	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-69618	Mitotic Spindle Checkpoint	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-210745	Regulation of gene expression in beta cells	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-2022870	Chondroitin sulfate biosynthesis	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-1181150	Signaling by NODAL	1.00000000000153	1.53370292053043e-12	21	0	0	246	10287
R-HSA-69202	Cyclin E associated events during G1/S transition	1.00000000000157	1.57486586079295e-12	72	0	0	246	10287
R-HSA-69052	Switching of origins to a post-replicative state	1.00000000000157	1.57486586079295e-12	72	0	0	246	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	1.00000000000157	1.57486586079295e-12	72	0	0	246	10287
R-HSA-68949	Orc1 removal from chromatin	1.00000000000157	1.57486586079295e-12	72	0	0	246	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	1.00000000000157	1.57486586079295e-12	72	0	0	246	10287
R-HSA-69481	G2/M Checkpoints	1.0000000000019	1.89550090339199e-12	169	0	0	246	10287
R-HSA-5658442	Regulation of RAS by GAPs	1.00000000000233	2.33182772303296e-12	70	0	0	246	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1.00000000000233	2.33182772303296e-12	70	0	0	246	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	1.00000000000234	2.33653660638047e-12	100	0	0	246	10287
R-HSA-74158	RNA Polymerase III Transcription	1.00000000000241	2.40903859470086e-12	41	0	0	246	10287
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1.00000000000241	2.40903859470086e-12	41	0	0	246	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	1.00000000000241	2.40903859470086e-12	41	0	0	246	10287
R-HSA-5696400	Dual Incision in GG-NER	1.00000000000241	2.40903859470086e-12	41	0	0	246	10287
R-HSA-5620924	Intraflagellar transport	1.00000000000241	2.40903859470086e-12	41	0	0	246	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	1.00000000000255	2.54592440121834e-12	191	0	0	246	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-70688	Proline catabolism	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-1483152	Hydrolysis of LPE	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-141424	Amplification of signal from the kinetochores	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-192905	vRNP Assembly	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-8849175	Threonine catabolism	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-111452	Activation and oligomerization of BAK protein	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-75064	mRNA Editing: A to I Conversion	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-380612	Metabolism of serotonin	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-351143	Agmatine biosynthesis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-888568	GABA synthesis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-8942233	Intestinal infectious diseases	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-75896	Plasmalogen biosynthesis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-156582	Acetylation	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-75102	C6 deamination of adenosine	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-165160	PDE3B signalling	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-205017	NFG and proNGF binds to p75NTR	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-844623	The IPAF inflammasome	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-111995	phospho-PLA2 pathway	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-6804754	Regulation of TP53 Expression	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-190872	Transport of connexons to the plasma membrane	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-114294	Activation, translocation and oligomerization of BAX	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-168268	Virus Assembly and Release	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-198765	Signalling to ERK5	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5652227	Fructose biosynthesis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5602566	TICAM1 deficiency - HSE	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-141334	PAOs oxidise polyamines to amines	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-1614603	Cysteine formation from homocysteine	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-187042	TRKA activation by NGF	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-916853	Degradation of GABA	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-71737	Pyrophosphate hydrolysis	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-5602636	IKBKB deficiency causes SCID	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-1483101	Synthesis of PS	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	1.00000000000278	2.77994727931885e-12	2	0	0	246	10287
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-2980766	Nuclear Envelope Breakdown	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-3214842	HDMs demethylate histones	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	1.00000000000324	3.23655179171235e-12	52	0	0	246	10287
R-HSA-69205	G1/S-Specific Transcription	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-5654704	SHC-mediated cascade:FGFR3	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-209776	Amine-derived hormones	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-1912420	Pre-NOTCH Processing in Golgi	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1.00000000000326	3.2570132189607e-12	18	0	0	246	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	1.000000000004	3.99941620035959e-12	32	0	0	246	10287
R-HSA-69190	DNA strand elongation	1.000000000004	3.99941620035959e-12	32	0	0	246	10287
R-HSA-68962	Activation of the pre-replicative complex	1.000000000004	3.99941620035959e-12	32	0	0	246	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	1.000000000004	3.99941620035959e-12	32	0	0	246	10287
R-HSA-2559585	Oncogene Induced Senescence	1.000000000004	3.99941620035959e-12	32	0	0	246	10287
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	1.000000000004	3.99941620035959e-12	32	0	0	246	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-6806003	Regulation of TP53 Expression and Degradation	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-2514856	The phototransduction cascade	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-176033	Interactions of Vpr with host cellular proteins	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	1.0000000000043	4.3001493136047e-12	36	0	0	246	10287
R-HSA-176187	Activation of ATR in response to replication stress	1.00000000000431	4.31113416347684e-12	37	0	0	246	10287
R-HSA-5689896	Ovarian tumor domain proteases	1.00000000000431	4.31113416347684e-12	37	0	0	246	10287
R-HSA-114452	Activation of BH3-only proteins	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-180786	Extension of Telomeres	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-5654733	Negative regulation of FGFR4 signaling	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-418990	Adherens junctions interactions	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-73772	RNA Polymerase I Promoter Escape	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	1.00000000000478	4.7759468008887e-12	31	0	0	246	10287
R-HSA-195253	Degradation of beta-catenin by the destruction complex	1.00000000000479	4.78848125010527e-12	83	0	0	246	10287
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000000526	5.25588461064374e-12	63	0	0	246	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.00000000000526	5.25588461064374e-12	63	0	0	246	10287
R-HSA-1632852	Macroautophagy	1.00000000000547	5.47243403274017e-12	67	0	0	246	10287
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	1.00000000000547	5.47243403274017e-12	67	0	0	246	10287
R-HSA-69615	G1/S DNA Damage Checkpoints	1.00000000000547	5.47243403274017e-12	67	0	0	246	10287
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1.00000000000547	5.47243403274017e-12	67	0	0	246	10287
R-HSA-8848021	Signaling by PTK6	1.00000000000547	5.47243403274017e-12	67	0	0	246	10287
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	1.00000000000554	5.54162388291865e-12	56	0	0	246	10287
R-HSA-4641257	Degradation of AXIN	1.00000000000554	5.54162388291865e-12	56	0	0	246	10287
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	1.00000000000554	5.54162388291865e-12	56	0	0	246	10287
R-HSA-69541	Stabilization of p53	1.00000000000554	5.54162388291865e-12	56	0	0	246	10287
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000000554	5.54162388291865e-12	56	0	0	246	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.0000000000057	5.70391529538973e-12	99	0	0	246	10287
R-HSA-112409	RAF-independent MAPK1/3 activation	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-5654693	FRS-mediated FGFR1 signaling	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-5205647	Mitophagy	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	1.00000000000584	5.83909076353694e-12	23	0	0	246	10287
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	1.000000000006	5.99869292447685e-12	73	0	0	246	10287
R-HSA-3214841	PKMTs methylate histone lysines	1.000000000006	5.99869292447685e-12	73	0	0	246	10287
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	1.000000000006	5.99869292447685e-12	73	0	0	246	10287
R-HSA-199992	trans-Golgi Network Vesicle Budding	1.000000000006	5.99869292447685e-12	73	0	0	246	10287
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	1.000000000006	5.99869292447685e-12	73	0	0	246	10287
R-HSA-421837	Clathrin derived vesicle budding	1.000000000006	5.99869292447685e-12	73	0	0	246	10287
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	1.00000000000612	6.11755390693838e-12	45	0	0	246	10287
R-HSA-8854214	TBC/RABGAPs	1.00000000000612	6.11755390693838e-12	45	0	0	246	10287
R-HSA-379724	tRNA Aminoacylation	1.00000000000612	6.11755390693838e-12	45	0	0	246	10287
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	1.00000000000612	6.11755390693838e-12	45	0	0	246	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	1.00000000000612	6.11755390693838e-12	45	0	0	246	10287
R-HSA-69304	Regulation of DNA replication	1.00000000000623	6.23014566208301e-12	77	0	0	246	10287
R-HSA-167172	Transcription of the HIV genome	1.00000000000623	6.23014566208301e-12	77	0	0	246	10287
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	1.00000000000623	6.23014566208301e-12	77	0	0	246	10287
R-HSA-170834	Signaling by TGF-beta Receptor Complex	1.00000000000623	6.23014566208301e-12	77	0	0	246	10287
R-HSA-8866376	Reelin signalling pathway	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-426048	Arachidonate production from DAG	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-390651	Dopamine receptors	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-68911	G2 Phase	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-70370	Galactose catabolism	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-6785470	tRNA processing in the mitochondrion	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-1169092	Activation of RAS in B cells	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-1483226	Synthesis of PI	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-8875513	MET interacts with TNS proteins	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-2161517	Abacavir transmembrane transport	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-187024	NGF-independant TRKA activation	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-112303	Electric Transmission Across Gap Junctions	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-114516	Disinhibition of SNARE formation	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-203641	NOSTRIN mediated eNOS trafficking	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111448	Activation of NOXA and translocation to mitochondria	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-71032	Propionyl-CoA catabolism	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-75157	FasL/ CD95L signaling	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-112307	Transmission across Electrical Synapses	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-2142850	Hyaluronan biosynthesis and export	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-446205	Synthesis of GDP-mannose	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-74713	IRS activation	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-71262	Carnitine synthesis	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-111463	SMAC binds to IAPs	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-391906	Leukotriene receptors	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-444209	Free fatty acid receptors	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-8849473	PTK6 Expression	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-1306955	GRB7 events in ERBB2 signaling	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-157881	Cyclin B2 mediated events	1.00000000000641	6.41117981581259e-12	5	0	0	246	10287
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	1.00000000000648	6.48281161993333e-12	104	0	0	246	10287
R-HSA-446728	Cell junction organization	1.00000000000658	6.58140688490796e-12	88	0	0	246	10287
R-HSA-912446	Meiotic recombination	1.00000000000658	6.58140688490796e-12	88	0	0	246	10287
R-HSA-5389840	Mitochondrial translation elongation	1.00000000000658	6.58140688490796e-12	88	0	0	246	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	1.00000000000658	6.58140688490796e-12	88	0	0	246	10287
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	1.00000000000689	6.89296794626987e-12	71	0	0	246	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.00000000000689	6.89296794626987e-12	71	0	0	246	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	1.00000000000689	6.89296794626987e-12	71	0	0	246	10287
R-HSA-5619507	Activation of HOX genes during differentiation	1.00000000000698	6.97865051763207e-12	126	0	0	246	10287
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	1.00000000000698	6.97865051763207e-12	126	0	0	246	10287
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	1.00000000000709	7.08801668411679e-12	64	0	0	246	10287
R-HSA-68875	Mitotic Prophase	1.00000000000739	7.3908201824804e-12	141	0	0	246	10287
R-HSA-165159	mTOR signalling	1.0000000000074	7.39973195728756e-12	39	0	0	246	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	1.0000000000074	7.39973195728756e-12	39	0	0	246	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	1.0000000000074	7.39973195728756e-12	39	0	0	246	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	1.0000000000074	7.39973195728756e-12	39	0	0	246	10287
R-HSA-6783310	Fanconi Anemia Pathway	1.0000000000074	7.39973195728756e-12	39	0	0	246	10287
R-HSA-5674135	MAP2K and MAPK activation	1.0000000000074	7.39973195728756e-12	39	0	0	246	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	1.00000000000755	7.54779276340403e-12	57	0	0	246	10287
R-HSA-432722	Golgi Associated Vesicle Biogenesis	1.00000000000755	7.54779276340403e-12	57	0	0	246	10287
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1.00000000000755	7.54779276340403e-12	57	0	0	246	10287
R-HSA-211000	Gene Silencing by RNA	1.00000000000768	7.68186776681554e-12	137	0	0	246	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	1.00000000000768	7.68186776681554e-12	137	0	0	246	10287
R-HSA-6799198	Complex I biogenesis	1.00000000000786	7.86037884991401e-12	51	0	0	246	10287
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	1.00000000000786	7.86037884991401e-12	51	0	0	246	10287
R-HSA-171306	Packaging Of Telomere Ends	1.00000000000786	7.86037884991401e-12	51	0	0	246	10287
R-HSA-1461973	Defensins	1.00000000000786	7.86037884991401e-12	51	0	0	246	10287
R-HSA-901042	Calnexin/calreticulin cycle	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-380994	ATF4 activates genes	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-77387	Insulin receptor recycling	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000000812	8.11586701022707e-12	27	0	0	246	10287
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-5610783	Degradation of GLI2 by the proteasome	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-421270	Cell-cell junction organization	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	1.0000000000085	8.49590096382396e-12	61	0	0	246	10287
R-HSA-453276	Regulation of mitotic cell cycle	1.00000000000958	9.57798200866349e-12	87	0	0	246	10287
R-HSA-5419276	Mitochondrial translation termination	1.00000000000958	9.57798200866349e-12	87	0	0	246	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1.00000000000958	9.57798200866349e-12	87	0	0	246	10287
R-HSA-5368286	Mitochondrial translation initiation	1.00000000000958	9.57798200866349e-12	87	0	0	246	10287
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	1.00000000000958	9.57798200866349e-12	87	0	0	246	10287
R-HSA-109606	Intrinsic Pathway for Apoptosis	1.00000000000966	9.66260015166313e-12	44	0	0	246	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.00000000000966	9.66260015166313e-12	44	0	0	246	10287
R-HSA-3232118	SUMOylation of transcription factors	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-189445	Metabolism of porphyrins	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-435354	Zinc transporters	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-622312	Inflammasomes	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-192456	Digestion of dietary lipid	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-156711	Polo-like kinase mediated events	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-5656121	Translesion synthesis by POLI	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-193639	p75NTR signals via NF-kB	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-5655862	Translesion synthesis by POLK	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-1482922	Acyl chain remodelling of PI	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-2142845	Hyaluronan metabolism	1.00000000001022	1.02164816473885e-11	17	0	0	246	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	1.00000000001026	1.0257295095288e-11	85	0	0	246	10287
R-HSA-166786	Creation of C4 and C2 activators	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-203615	eNOS activation	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-844456	The NLRP3 inflammasome	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-209822	Glycoprotein hormones	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-210990	PECAM1 interactions	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-8851680	Butyrophilin (BTN) family interactions	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-1236977	Endosomal/Vacuolar pathway	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-176974	Unwinding of DNA	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-2033514	FGFR3 mutant receptor activation	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-73621	Pyrimidine catabolism	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-5689877	Josephin domain DUBs	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-1433617	Regulation of signaling by NODAL	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-2160916	Hyaluronan uptake and degradation	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-1839130	Signaling by activated point mutants of FGFR3	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-3371511	HSF1 activation	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-390666	Serotonin receptors	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-71064	Lysine catabolism	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-211958	Miscellaneous substrates	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-8866427	VLDLR internalisation and degradation	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-4641265	Repression of WNT target genes	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-5578768	Physiological factors	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000001071	1.07084651775479e-11	12	0	0	246	10287
R-HSA-5693607	Processing of DNA double-strand break ends	1.00000000001081	1.08112730506756e-11	98	0	0	246	10287
R-HSA-427413	NoRC negatively regulates rRNA expression	1.0000000000109	1.08969055093113e-11	107	0	0	246	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-447043	Neurofascin interactions	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-199920	CREB phosphorylation	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-174362	Transport and synthesis of PAPS	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-447038	NrCAM interactions	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-111471	Apoptotic factor-mediated response	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-429593	Inositol transporters	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-174577	Activation of C3 and C5	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-171319	Telomere Extension By Telomerase	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-448706	Interleukin-1 processing	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-164843	2-LTR circle formation	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-75158	TRAIL  signaling	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-5619102	SLC transporter disorders	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000001091	1.09140813123933e-11	7	0	0	246	10287
R-HSA-164516	Minus-strand DNA synthesis	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-8853333	Signaling by FGFR2 fusions	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-169131	Inhibition of PKR	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-140180	COX reactions	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1222449	Mtb iron assimilation by chelation	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1839128	FGFR4 mutant receptor activation	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1222499	Response of Mtb to phagocytosis	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-164525	Plus-strand DNA synthesis	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1300645	Acrosome Reaction	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5602410	TLR3 deficiency - HSE	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-163316	Mitochondrial transcription termination	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-6809583	Retinoid metabolism disease events	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2408552	Methylation of MeSeH for excretion	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-162585	Uncoating of the HIV Virion	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-162589	Reverse Transcription of HIV RNA	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-3248023	Regulation by TREX1	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2534343	Interaction With Cumulus Cells	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-389542	NADPH regeneration	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-1483076	Synthesis of CL	1.00000000001124	1.12392144202555e-11	1	0	0	246	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-8874081	MET activates PTK2 signaling	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-5654719	SHC-mediated cascade:FGFR4	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-8876384	Listeria monocytogenes entry into host cells	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-69186	Lagging Strand Synthesis	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-194223	HDL-mediated lipid transport	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-5654706	FRS-mediated FGFR3 signaling	1.00000000001132	1.1319735329766e-11	20	0	0	246	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1.00000000001156	1.15646944165094e-11	49	0	0	246	10287
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	1.00000000001156	1.15646944165094e-11	49	0	0	246	10287
R-HSA-6783783	Interleukin-10 signaling	1.00000000001156	1.15646944165094e-11	49	0	0	246	10287
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000001179	1.178504276806e-11	105	0	0	246	10287
R-HSA-5689603	UCH proteinases	1.00000000001179	1.178504276806e-11	105	0	0	246	10287
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1.00000000001203	1.20264183511572e-11	84	0	0	246	10287
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	1.00000000001216	1.21560083792782e-11	58	0	0	246	10287
R-HSA-381070	IRE1alpha activates chaperones	1.00000000001216	1.21560083792782e-11	58	0	0	246	10287
R-HSA-168255	Influenza Life Cycle	1.00000000001226	1.22587824479593e-11	146	0	0	246	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.00000000001253	1.25318432209229e-11	43	0	0	246	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	1.00000000001253	1.25318432209229e-11	43	0	0	246	10287
R-HSA-75893	TNF signaling	1.00000000001253	1.25318432209229e-11	43	0	0	246	10287
R-HSA-168325	Viral Messenger RNA Synthesis	1.00000000001253	1.25318432209229e-11	43	0	0	246	10287
R-HSA-162906	HIV Infection	1.00000000001338	1.33813958693331e-11	236	0	0	246	10287
R-HSA-2299718	Condensation of Prophase Chromosomes	1.00000000001373	1.37285472833058e-11	74	0	0	246	10287
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000001373	1.37285472833058e-11	74	0	0	246	10287
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	1.00000000001373	1.37285472833058e-11	74	0	0	246	10287
R-HSA-69300	Removal of licensing factors from origins	1.00000000001373	1.37285472833058e-11	74	0	0	246	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-180534	Vpu mediated degradation of CD4	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-194441	Metabolism of non-coding RNA	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-191859	snRNP Assembly	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-5620920	Cargo trafficking to the periciliary membrane	1.00000000001392	1.39209915766144e-11	53	0	0	246	10287
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	1.00000000001397	1.39719001175505e-11	247	0	0	246	10287
R-HSA-1500620	Meiosis	1.00000000001449	1.44898649780384e-11	121	0	0	246	10287
R-HSA-2408522	Selenoamino acid metabolism	1.00000000001449	1.44898649780384e-11	121	0	0	246	10287
R-HSA-167287	HIV elongation arrest and recovery	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-1442490	Collagen degradation	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-5675221	Negative regulation of MAPK pathway	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-168276	NS1 Mediated Effects on Host Pathways	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-109703	PKB-mediated events	1.00000000001498	1.49806674089394e-11	40	0	0	246	10287
R-HSA-186712	Regulation of beta-cell development	1.00000000001535	1.53458791568799e-11	33	0	0	246	10287
R-HSA-5357905	Regulation of TNFR1 signaling	1.00000000001535	1.53458791568799e-11	33	0	0	246	10287
R-HSA-1222556	ROS, RNS production in phagocytes	1.00000000001535	1.53458791568799e-11	33	0	0	246	10287
R-HSA-180746	Nuclear import of Rev protein	1.00000000001535	1.53458791568799e-11	33	0	0	246	10287
R-HSA-180910	Vpr-mediated nuclear import of PICs	1.00000000001535	1.53458791568799e-11	33	0	0	246	10287
R-HSA-5654726	Negative regulation of FGFR1 signaling	1.00000000001535	1.53458791568799e-11	33	0	0	246	10287
R-HSA-69275	G2/M Transition	1.00000000001569	1.56938775386046e-11	182	0	0	246	10287
R-HSA-73857	RNA Polymerase II Transcription	1.00000000001578	1.57825341935853e-11	159	0	0	246	10287
R-HSA-73854	RNA Polymerase I Promoter Clearance	1.00000000001579	1.5790321617929e-11	110	0	0	246	10287
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	1.00000000001579	1.5790321617929e-11	110	0	0	246	10287
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	1.00000000001579	1.5790321617929e-11	110	0	0	246	10287
R-HSA-5578749	Transcriptional regulation by small RNAs	1.00000000001654	1.65392062953904e-11	106	0	0	246	10287
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1.00000000001665	1.6645790089707e-11	149	0	0	246	10287
R-HSA-162599	Late Phase of HIV Life Cycle	1.00000000001706	1.70591444543644e-11	139	0	0	246	10287
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	1.00000000001726	1.72576934442267e-11	42	0	0	246	10287
R-HSA-1461957	Beta defensins	1.00000000001726	1.72576934442267e-11	42	0	0	246	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1.00000000001726	1.72576934442267e-11	42	0	0	246	10287
R-HSA-373752	Netrin-1 signaling	1.00000000001726	1.72576934442267e-11	42	0	0	246	10287
R-HSA-168253	Host Interactions with Influenza Factors	1.00000000001726	1.72576934442267e-11	42	0	0	246	10287
R-HSA-72187	mRNA 3'-end processing	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-8852135	Protein ubiquitination	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-1268020	Mitochondrial protein import	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-72649	Translation initiation complex formation	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-5678895	Defective CFTR causes cystic fibrosis	1.00000000001735	1.73548511778119e-11	62	0	0	246	10287
R-HSA-3214815	HDACs deacetylate histones	1.00000000001743	1.742790411071e-11	94	0	0	246	10287
R-HSA-5368287	Mitochondrial translation	1.00000000001743	1.742790411071e-11	94	0	0	246	10287
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	1.00000000001754	1.75379986863414e-11	93	0	0	246	10287
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	1.00000000001754	1.75379986863414e-11	93	0	0	246	10287
R-HSA-6802957	Oncogenic MAPK signaling	1.00000000001785	1.78536065374864e-11	75	0	0	246	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000001785	1.78536065374864e-11	75	0	0	246	10287
R-HSA-8854518	AURKA Activation by TPX2	1.00000000001785	1.78536065374864e-11	75	0	0	246	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000001785	1.78536065374864e-11	75	0	0	246	10287
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-169911	Regulation of Apoptosis	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-189200	Hexose transport	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-69610	p53-Independent DNA Damage Response	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-1592230	Mitochondrial biogenesis	1.00000000001787	1.78733663146753e-11	54	0	0	246	10287
R-HSA-168254	Influenza Infection	1.00000000001827	1.82706295556412e-11	157	0	0	246	10287
R-HSA-3214847	HATs acetylate histones	1.00000000001834	1.83393996501093e-11	143	0	0	246	10287
R-HSA-156902	Peptide chain elongation	1.0000000000184	1.83976574260356e-11	92	0	0	246	10287
R-HSA-192823	Viral mRNA Translation	1.0000000000184	1.83976574260356e-11	92	0	0	246	10287
R-HSA-381119	Unfolded Protein Response (UPR)	1.0000000000184	1.83976574260356e-11	92	0	0	246	10287
R-HSA-611105	Respiratory electron transport	1.0000000000184	1.83976574260356e-11	92	0	0	246	10287
R-HSA-5334118	DNA methylation	1.00000000001868	1.86832018184728e-11	65	0	0	246	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000001868	1.86832018184728e-11	65	0	0	246	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000001868	1.86832018184728e-11	65	0	0	246	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000001868	1.86832018184728e-11	65	0	0	246	10287
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	1.00000000001868	1.86832018184728e-11	65	0	0	246	10287
R-HSA-69563	p53-Dependent G1 DNA Damage Response	1.00000000001868	1.86832018184728e-11	65	0	0	246	10287
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	1.00000000001875	1.87548003360768e-11	55	0	0	246	10287
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	1.00000000001875	1.87548003360768e-11	55	0	0	246	10287
R-HSA-180585	Vif-mediated degradation of APOBEC3G	1.00000000001875	1.87548003360768e-11	55	0	0	246	10287
R-HSA-5607764	CLEC7A (Dectin-1) signaling	1.00000000001894	1.89430963044233e-11	101	0	0	246	10287
R-HSA-69239	Synthesis of DNA	1.00000000001894	1.89430963044233e-11	101	0	0	246	10287
R-HSA-212165	Epigenetic regulation of gene expression	1.00000000001947	1.94729700398729e-11	151	0	0	246	10287
R-HSA-5693538	Homology Directed Repair	1.00000000001952	1.95169428450727e-11	138	0	0	246	10287
R-HSA-73864	RNA Polymerase I Transcription	1.00000000001967	1.96741681909349e-11	112	0	0	246	10287
R-HSA-5696398	Nucleotide Excision Repair	1.00000000001967	1.96741681909349e-11	112	0	0	246	10287
R-HSA-6782135	Dual incision in TC-NER	1.0000000000198	1.97971161174498e-11	66	0	0	246	10287
R-HSA-72312	rRNA processing	1.00000000001983	1.98286706690477e-11	201	0	0	246	10287
R-HSA-69620	Cell Cycle Checkpoints	1.00000000001983	1.98286706690477e-11	201	0	0	246	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	1.00000000002017	2.01705584760324e-11	90	0	0	246	10287
R-HSA-5687128	MAPK6/MAPK4 signaling	1.00000000002017	2.01705584760324e-11	90	0	0	246	10287
R-HSA-69242	S Phase	1.00000000002053	2.0532977648537e-11	130	0	0	246	10287
R-HSA-72766	Translation	1.00000000002105	2.10460242395034e-11	162	0	0	246	10287
R-HSA-72172	mRNA Splicing	1.00000000002116	2.11566876220642e-11	195	0	0	246	10287
R-HSA-2408557	Selenocysteine synthesis	1.00000000002178	2.17812633809084e-11	95	0	0	246	10287
R-HSA-69473	G2/M DNA damage checkpoint	1.00000000002178	2.17812633809084e-11	95	0	0	246	10287
R-HSA-5619115	Disorders of transmembrane transporters	1.00000000002199	2.19924338905231e-11	76	0	0	246	10287
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	1.00000000002199	2.19924338905231e-11	76	0	0	246	10287
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	1.00000000002199	2.19924338905231e-11	76	0	0	246	10287
R-HSA-5693606	DNA Double Strand Break Response	1.00000000002199	2.19924338905231e-11	76	0	0	246	10287
R-HSA-73777	RNA Polymerase I Chain Elongation	1.00000000002244	2.24407343313209e-11	91	0	0	246	10287
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	1.00000000002244	2.24407343313209e-11	91	0	0	246	10287
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	1.00000000002244	2.24407343313209e-11	91	0	0	246	10287
R-HSA-162587	HIV Life Cycle	1.00000000002244	2.24424258129981e-11	152	0	0	246	10287
R-HSA-162909	Host Interactions of HIV factors	1.00000000002289	2.28865242097648e-11	134	0	0	246	10287
R-HSA-5693532	DNA Double-Strand Break Repair	1.00000000002291	2.29143311851145e-11	167	0	0	246	10287
R-HSA-3214858	RMTs methylate histone arginines	1.000000000023	2.30020934478853e-11	79	0	0	246	10287
R-HSA-2871837	FCERI mediated NF-kB activation	1.000000000023	2.30020934478853e-11	79	0	0	246	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.000000000023	2.30020934478853e-11	79	0	0	246	10287
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.000000000023	2.30020934478853e-11	79	0	0	246	10287
R-HSA-1221632	Meiotic synapsis	1.000000000023	2.30020934478853e-11	79	0	0	246	10287
R-HSA-3247509	Chromatin modifying enzymes	1.00000000002357	2.35695140869303e-11	279	0	0	246	10287
R-HSA-4839726	Chromatin organization	1.00000000002357	2.35695140869303e-11	279	0	0	246	10287
R-HSA-69306	DNA Replication	1.00000000002488	2.48840192995513e-11	109	0	0	246	10287
R-HSA-453274	Mitotic G2-G2/M phases	1.00000000002511	2.51103691374649e-11	184	0	0	246	10287
R-HSA-1852241	Organelle biogenesis and maintenance	1.00000000002539	2.53934956290148e-11	340	0	0	246	10287
R-HSA-69206	G1/S Transition	1.00000000002582	2.5822753865155e-11	119	0	0	246	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.00000000002643	2.64266336539382e-11	115	0	0	246	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000002662	2.66231971100471e-11	120	0	0	246	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000002662	2.66231971100471e-11	120	0	0	246	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000002681	2.68071477832848e-11	38	0	0	246	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000002681	2.68071477832848e-11	38	0	0	246	10287
R-HSA-5689901	Metalloprotease DUBs	1.00000000002681	2.68071477832848e-11	38	0	0	246	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000002681	2.68071477832848e-11	38	0	0	246	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000002806	2.80643499377092e-11	117	0	0	246	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000002806	2.80643499377092e-11	117	0	0	246	10287
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	1.00000000002876	2.87584960608788e-11	108	0	0	246	10287
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	1.00000000003021	3.0206280784181e-11	68	0	0	246	10287
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1.00000000003021	3.0206280784181e-11	68	0	0	246	10287
R-HSA-1169091	Activation of NF-kappaB in B cells	1.00000000003021	3.0206280784181e-11	68	0	0	246	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000003021	3.0206280784181e-11	68	0	0	246	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000003174	3.17422507956438e-11	187	0	0	246	10287
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	1.00000000003399	3.39909674759832e-11	132	0	0	246	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000003434	3.43427662509052e-11	179	0	0	246	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000003556	3.55585075416377e-11	125	0	0	246	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000003556	3.55585075416377e-11	125	0	0	246	10287
R-HSA-5617833	Cilium Assembly	1.00000000003937	3.93704057410394e-11	192	0	0	246	10287
